TSS:Rfhg 214944.1

Basic information about the TSS

---

TSS ID: rfhg_214944.1 Species: human Chr: chr19		Start: 49855024 End: 49855041 Strand: +
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000600105.5:14 GeneID: 53635 HGNC/MGI_ID: HGNC:9632 UniProt_ID: Nearer transcript ids and distances:

Gene_name: MIR4749 Gene_symbol: PTOV1 Gene_synonyms: Gene_source: HGNC:9632

TATA-Box annotation

---

Distance to TSS:	441
Nearest PromoterID:	NR_039904
Entrez ID:	100616313
Nearest Unigene:
Nearest Refseq:	NR_039904
Nearest Ensembl:	ENSG00000265954
Gene Name:	MIR4749
Gene Alias:	mir-4749
Gene Type:	ncRNA
CpG%:	0.117647
GC%:	0.555556
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PTOV1 p2@PTOV1 p3@PTOV1 p4@PTOV1 p5@PTOV1 p6@PTOV1 p7@PTOV1 p8@PTOV1 p9@PTOV1 p10@PTOV1
Sample		p1@PTOV1	p2@PTOV1	p3@PTOV1	p4@PTOV1	p5@PTOV1	p6@PTOV1	p7@PTOV1	p8@PTOV1	p9@PTOV1	p10@PTOV1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	52.60	52.40	4.68	7.79	4.09	2.53	0.39	1.17	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	54.42	56.04	4.65	6.47	4.25	1.42	1.21	2.23	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	44.75	45.72	2.89	7.14	2.89	2.70	1.54	0.96	0.19	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	45.53	42.00	3.12	5.41	3.95	1.66	1.25	1.25	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	49.72	59.84	2.92	9.22	3.37	2.92	2.02	2.25	0.45	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	43.61	51.94	3.10	7.36	2.33	0.97	1.74	1.74	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	39.87	55.12	2.40	7.84	3.27	3.70	0.87	2.18	0.00	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	42.39	46.02	2.18	4.36	3.63	4.36	1.70	1.94	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	51.51	47.23	5.13	6.84	2.78	2.56	0.85	0.21	0.21	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	26.66	35.94	3.48	3.48	2.32	6.96	1.16	1.74	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	33.55	32.34	1.62	4.04	2.02	3.23	2.02	1.21	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	31.30	29.27	2.85	4.07	0.81	7.32	0.81	0.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	42.72	36.59	5.80	4.03	1.61	1.61	0.64	1.93	1.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	31.27	28.87	4.36	3.91	1.65	0.75	0.15	1.65	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	36.45	30.74	5.27	5.49	2.20	0.44	0.88	1.98	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	32.69	31.18	5.28	4.02	1.76	1.01	0.00	1.51	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	31.89	29.48	4.15	4.37	2.18	0.22	0.44	0.87	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	30.79	24.89	5.48	5.48	3.37	1.69	0.42	2.11	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	26.12	21.33	2.67	2.13	1.60	1.07	0.00	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	28.88	27.53	3.61	1.65	1.50	0.90	0.30	1.35	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	29.00	27.13	5.21	3.47	2.00	0.94	0.00	1.07	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	27.79	25.55	2.93	3.28	1.38	1.38	0.52	1.04	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	29.47	27.79	4.91	3.10	1.29	0.52	0.13	1.29	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	38.58	35.91	4.37	3.40	4.37	0.24	0.97	1.21	0.73	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	30.96	27.35	3.61	3.35	2.32	1.55	0.00	2.58	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	40.83	35.45	5.06	4.43	2.22	1.27	0.32	1.58	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	29.12	31.32	2.75	4.40	2.20	2.20	0.55	0.55	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	41.26	33.95	4.24	4.72	3.54	1.18	0.24	1.18	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	32.30	31.01	4.52	4.04	1.13	0.97	0.48	1.62	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	33.66	27.14	4.71	3.44	1.81	0.90	0.36	1.45	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	30.15	22.61	5.23	2.72	2.30	2.09	0.21	1.05	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	26.77	23.84	3.52	3.52	2.15	0.98	0.00	0.78	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	21.31	23.64	4.85	2.95	0.84	0.84	0.21	1.69	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	16.82	20.62	2.47	1.15	1.48	0.82	0.00	0.66	0.66	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	28.24	26.37	4.11	3.37	1.68	0.75	0.93	1.87	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	27.02	27.40	3.45	3.45	2.30	1.15	0.00	0.57	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	34.13	27.59	4.29	3.68	2.25	0.41	0.41	1.43	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	31.23	24.38	5.44	4.63	1.01	0.60	0.20	1.41	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	35.65	26.20	3.24	3.51	1.62	1.08	0.00	1.08	1.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	31.21	29.77	5.52	5.04	1.44	1.44	0.00	0.72	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	33.41	28.47	3.53	2.59	1.65	0.47	0.00	1.18	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	20.64	24.30	3.51	2.64	1.46	0.44	0.29	1.61	0.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	31.00	20.25	4.43	4.43	1.69	0.84	0.42	1.27	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	31.64	30.77	5.24	3.50	2.10	1.05	0.35	0.17	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	34.73	29.51	5.82	3.61	2.01	1.41	0.20	1.61	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	33.27	26.52	4.65	3.49	1.86	0.93	0.70	1.16	0.70	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	36.23	28.79	3.60	2.64	2.16	0.96	0.48	1.92	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	32.79	25.63	3.87	2.68	1.79	1.79	0.00	2.09	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	29.68	24.42	4.31	3.11	1.20	0.00	0.48	1.44	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	27.70	23.66	4.65	2.83	2.22	0.81	0.00	0.40	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	21.32	21.11	3.28	2.05	1.84	1.02	0.41	0.82	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	24.24	29.13	4.00	2.22	1.11	2.67	0.22	1.78	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00	0.00	0.00	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	22.36	14.19	4.61	2.13	1.77	1.77	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	23.86	16.57	3.65	3.31	0.99	0.99	0.66	1.66	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	12.58	20.13	1.68	2.52	1.68	1.68	0.84	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	14.70	14.70	0.92	2.30	0.46	1.38	0.00	0.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	17.83	14.91	3.24	3.24	1.62	1.94	0.00	2.27	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	20.88	15.42	3.21	2.89	0.32	1.61	0.32	0.96	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	14.14	14.46	0.63	0.94	0.63	0.31	0.31	1.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	23.27	15.51	4.94	3.53	0.71	0.71	0.00	0.71	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	24.67	14.02	3.93	2.80	2.24	1.12	0.00	2.80	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.94	23.09	1.59	1.59	0.80	1.59	0.00	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	11.89	8.49	1.70	0.34	0.68	0.68	0.00	0.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	16.25	13.00	2.92	1.30	1.30	1.30	0.32	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	17.04	12.42	4.97	0.71	4.26	1.06	0.71	0.71	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	32.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	20.96	12.68	4.88	0.49	0.98	0.00	0.00	0.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	15.37	14.38	6.45	0.99	2.48	2.48	0.00	0.99	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	16.89	11.26	3.28	0.47	1.41	0.47	0.00	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	15.90	8.94	3.97	0.99	0.66	0.00	0.00	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	14.54	10.21	3.40	1.24	1.24	0.62	0.31	0.31	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	19.87	11.31	3.67	0.31	1.53	0.92	0.00	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	19.64	19.01	1.90	2.06	1.74	1.43	0.16	0.63	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	15.24	16.04	3.21	2.41	1.12	1.28	0.00	0.64	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	13.61	12.47	2.16	2.80	1.78	1.78	0.25	0.25	0.00	0.00
Adipocyte - omental, donor2	11474-119C7	17.19	13.45	5.23	1.49	2.99	3.74	0.00	2.24	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	19.43	20.10	2.68	4.02	3.35	1.34	0.00	0.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	18.50	20.42	4.47	2.55	5.10	1.91	0.00	1.28	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	18.69	15.39	7.70	0.00	0.00	1.10	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	28.00	21.23	2.26	1.81	1.35	1.35	0.00	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	30.06	28.33	4.00	4.00	3.13	1.04	0.52	1.91	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	24.06	21.71	4.30	1.96	2.74	0.98	0.20	0.00	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	19.82	17.76	1.80	2.83	5.15	1.03	0.00	0.51	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	23.14	17.28	6.69	1.67	3.35	1.95	0.28	1.39	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	33.51	17.63	4.70	1.18	3.53	0.00	0.59	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	30.56	26.54	4.10	5.07	5.79	1.77	0.48	0.64	0.00	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	17.11	15.81	4.84	2.26	5.49	0.32	0.32	0.32	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	16.00	23.99	1.07	1.60	3.73	0.53	0.53	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	21.70	11.13	2.78	1.67	5.56	1.11	0.00	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	33.69	21.63	7.90	3.33	4.57	0.00	0.42	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	21.35	14.32	4.77	2.76	3.01	1.26	0.50	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	22.91	12.76	3.93	3.60	6.22	2.95	0.98	0.33	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	17.35	12.18	1.83	1.52	1.52	0.61	0.61	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	35.14	27.85	5.97	3.31	3.09	0.66	0.88	0.44	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	38.73	32.63	10.40	4.30	5.02	0.72	0.36	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	35.94	28.75	5.99	3.59	3.59	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	35.08	22.49	5.58	1.62	3.42	0.54	0.18	0.18	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	41.84	36.82	8.37	3.35	3.35	3.35	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	51.36	46.43	9.25	4.31	2.05	0.00	0.00	0.82	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	38.90	41.54	5.38	4.23	5.61	0.34	0.57	1.03	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	30.37	34.78	5.14	3.92	3.43	1.22	0.49	0.24	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	18.42	19.77	3.15	4.04	0.00	1.35	0.00	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	25.61	35.17	3.91	6.08	3.47	0.87	0.00	0.43	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	23.54	32.10	4.28	0.00	2.14	6.42	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	26.90	22.12	4.18	2.99	1.20	0.90	0.60	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	26.56	25.29	3.79	1.26	2.53	1.26	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	17.82	20.46	5.94	4.62	1.32	1.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	23.72	23.39	2.60	3.57	1.30	1.30	0.65	0.32	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	22.33	26.21	2.91	2.91	3.88	1.46	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	19.60	19.00	5.94	1.78	0.00	0.59	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	25.23	16.57	3.39	4.14	1.13	1.51	0.38	1.13	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.12	27.58	4.35	6.53	0.73	2.90	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	20.06	1.25	1.25	2.51	3.76	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	28.66	30.97	3.62	5.93	2.14	1.48	0.16	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	21.84	2.73	4.09	4.09	1.36	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	18.70	19.90	3.47	2.26	2.26	1.06	0.30	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	17.15	18.75	6.43	3.21	1.61	1.07	0.00	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	23.62	26.07	4.35	4.72	3.40	1.32	0.00	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	27.00	24.06	3.47	4.81	1.87	1.34	0.00	0.27	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	12.68	21.46	4.88	1.95	3.90	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	18.91	28.53	4.15	4.31	1.99	1.33	0.33	0.50	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	18.01	28.82	2.40	2.40	2.40	1.20	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	14.16	7.08	0.00	0.00	3.54	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	20.41	23.50	3.60	3.77	1.20	1.72	0.51	0.17	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	16.78	0.00	4.19	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	21.36	19.42	2.43	4.85	0.49	0.49	1.46	0.97	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	24.28	20.87	2.28	6.83	2.28	0.76	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	16.96	24.23	2.42	6.06	1.21	0.00	0.00	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.39	29.64	2.28	2.28	2.85	0.57	0.57	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	22.66	24.16	3.42	4.28	2.14	1.07	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	22.97	21.68	2.06	4.65	2.58	3.36	1.29	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	27.21	15.01	2.82	3.75	2.82	0.47	0.00	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	23.15	29.90	4.50	1.61	4.82	0.96	0.32	0.64	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	16.41	29.25	1.43	0.71	0.00	0.71	0.71	0.00	0.00	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	24.57	19.89	4.68	3.51	2.92	0.58	1.17	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	19.87	23.78	3.31	2.41	3.91	1.20	0.00	0.30	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	24.95	7.13	3.56	2.38	1.19	1.19	0.00	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	25.43	21.87	5.59	5.09	4.58	1.02	0.51	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	22.67	27.00	2.55	2.80	1.53	1.27	0.76	1.02	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	23.51	20.33	4.45	2.54	2.54	0.64	1.27	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	22.87	22.01	3.45	3.88	3.88	2.16	0.43	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	23.07	27.31	5.29	4.23	3.18	0.42	0.85	0.42	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	15.66	18.85	4.06	2.90	2.61	0.87	0.87	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	28.34	21.73	7.56	3.78	1.89	2.83	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	18.48	24.75	5.26	3.90	2.71	1.36	0.51	0.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	27.80	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	12.68	4.23	0.00	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	23.80	25.09	3.43	4.72	2.36	1.29	0.86	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	18.05	15.64	3.01	3.61	2.41	1.80	0.00	0.60	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	24.06	21.14	7.29	4.37	4.37	0.73	0.73	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	27.59	31.72	5.75	3.91	2.30	2.07	0.00	0.92	0.69	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	22.95	7.65	2.55	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	17.54	15.51	2.29	3.31	1.53	2.80	0.25	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	21.68	26.42	4.75	4.95	1.65	1.45	0.62	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	19.89	30.91	3.67	3.06	1.22	1.53	0.61	0.92	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	24.38	26.77	1.43	5.26	2.39	0.00	0.00	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	19.73	25.28	2.66	2.88	2.88	1.11	0.22	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	21.36	19.84	4.58	3.05	3.05	1.53	0.00	1.53	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	19.39	21.60	3.32	3.32	3.32	2.22	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	21.45	27.01	1.59	3.71	1.59	0.79	0.26	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	22.90	24.35	1.82	1.45	2.54	1.09	0.00	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	37.58	73.81	6.26	7.74	6.75	0.37	1.35	0.12	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	41.76	66.24	8.90	9.93	8.56	0.51	1.71	0.68	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	41.11	55.79	3.99	8.39	5.66	0.42	0.63	0.21	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	46.36	50.54	4.53	8.02	5.93	0.70	1.74	1.05	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	52.58	61.31	4.85	8.41	7.60	0.49	1.62	1.13	0.16	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	55.19	62.65	4.03	9.55	6.26	0.15	1.34	0.60	0.00	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	25.00	16.51	3.78	0.69	2.06	2.87	0.00	0.46	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	24.93	18.54	4.01	1.00	1.75	1.75	0.00	0.00	0.00	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	21.28	14.11	4.89	1.14	1.82	2.05	0.00	0.00	0.00	0.00
Basophils, donor1	12241-129G9	7.85	7.85	2.35	0.26	0.26	2.09	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	6.86	5.77	2.53	0.36	0.72	2.16	0.36	0.00	0.00	0.00
Basophils, donor3	12243-129H2	14.85	5.88	3.38	0.88	0.44	1.18	0.15	0.44	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	24.58	16.60	6.90	0.86	0.86	0.22	0.00	0.86	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	35.20	29.26	10.52	3.66	1.83	0.00	0.00	1.37	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	7.17	14.35	7.17	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	18.20	15.06	3.77	1.88	0.63	0.63	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	28.49	30.57	6.24	4.57	1.25	0.00	0.42	0.83	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	14.28	14.28	3.45	0.69	1.15	0.69	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	22.49	16.38	4.86	1.26	0.90	0.00	0.00	0.36	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	14.32	12.37	1.85	5.26	2.89	0.00	1.44	0.10	0.10	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	14.91	15.14	1.16	0.70	1.40	0.47	0.23	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	24.62	23.02	3.20	4.80	3.52	2.56	0.96	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	20.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	6.20	3.94	4.51	0.00	1.13	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	8.91	8.17	2.60	0.74	0.56	1.11	0.00	0.19	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	13.39	7.46	4.17	1.10	0.66	1.76	0.22	0.44	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	15.28	5.94	5.09	0.57	1.98	1.13	0.00	0.85	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	13.65	8.34	4.93	0.76	1.14	1.52	0.00	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	15.45	7.56	4.27	0.66	0.33	0.66	0.00	0.00	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	10.84	6.65	2.46	0.87	0.72	0.87	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	5.73	5.13	1.81	0.00	0.30	0.60	0.30	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	7.34	4.97	0.95	0.24	0.95	0.71	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	6.36	4.69	1.51	0.33	0.17	0.67	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.97	3.31	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	6.69	6.45	0.74	0.00	0.00	0.50	0.25	0.25	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.09	4.31	1.37	0.00	0.20	0.20	0.00	0.20	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	5.16	2.85	2.14	0.18	0.00	0.18	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.22	5.66	1.09	0.44	0.44	0.65	0.00	0.22	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	6.09	3.04	2.11	0.23	0.23	0.70	0.23	0.23	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.86	3.17	2.11	0.00	1.06	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	9.98	5.55	1.11	0.00	0.00	0.00	0.00	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	6.10	5.06	2.83	0.15	0.30	0.74	0.15	0.15	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	3.79	2.59	1.40	0.00	0.20	0.80	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	6.04	4.16	1.67	0.62	0.00	0.42	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.41	3.66	2.06	0.46	0.46	0.46	0.00	0.69	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	5.43	4.52	1.58	0.23	0.23	0.23	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.98	4.80	1.31	0.00	0.44	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	5.65	4.30	1.88	0.27	0.54	0.27	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	4.71	5.41	1.74	0.35	0.17	0.35	0.00	0.17	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	7.15	2.95	2.52	0.00	0.42	0.42	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.33	4.41	1.47	0.37	0.18	0.18	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.23	1.76	0.70	0.70	0.35	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5.26	3.51	1.32	0.44	0.00	0.88	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	9.76	4.18	2.44	0.52	0.17	0.35	0.00	0.17	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	8.18	1.86	2.60	0.37	0.00	0.37	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	6.04	4.74	1.51	0.22	0.22	0.43	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	9.01	8.19	4.09	0.00	0.82	0.41	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	5.10	1.62	0.70	0.00	0.23	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3.94	4.41	1.16	0.00	0.23	0.23	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	6.97	3.71	2.40	0.00	0.22	0.22	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	9.93	4.62	3.23	0.00	0.46	0.69	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	8.23	2.82	2.82	0.22	1.73	0.00	0.22	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	16.35	4.52	4.67	0.62	1.56	1.40	0.16	0.31	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	13.45	5.24	4.19	0.52	0.87	1.40	0.00	0.00	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	11.15	3.79	4.24	0.22	0.45	0.89	0.22	0.00	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	7.91	5.61	5.61	0.00	0.00	2.04	0.00	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	7.03	4.61	3.29	0.88	0.22	0.22	0.00	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	6.32	4.21	4.42	0.21	0.00	0.63	0.21	0.42	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	38.61	2.03	6.10	4.06	0.00	0.00	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	23.73	23.73	1.36	1.36	2.71	1.36	1.36	1.36	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	21.75	21.75	1.04	2.07	3.11	0.00	0.00	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	19.19	24.52	2.67	4.26	1.07	0.00	1.60	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	26.27	31.63	3.22	1.61	5.36	2.14	0.00	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	14.74	19.65	1.40	1.40	6.32	1.40	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	29.02	22.75	1.57	1.57	0.78	1.57	0.00	0.78	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	23.73	26.37	2.64	0.00	1.32	3.95	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	29.59	18.08	1.64	4.93	1.64	2.47	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	13.06	21.04	2.90	1.45	2.18	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	14.64	16.66	1.01	4.54	1.51	1.01	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	18.18	8.08	6.46	0.81	0.81	0.81	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	16.78	6.39	10.79	0.40	1.20	1.60	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	11.04	25.10	1.00	4.02	3.01	0.00	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	3.93	20.23	1.69	2.81	1.69	0.56	0.56	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	19.92	22.92	3.76	3.76	2.63	0.75	0.75	0.75	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	20.29	22.77	4.74	1.35	2.93	0.68	0.90	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	17.50	20.35	3.57	0.36	1.43	3.57	1.07	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	23.27	25.11	3.67	3.06	1.84	3.06	0.61	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	18.30	19.82	4.88	2.44	1.22	1.22	0.00	0.30	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	19.91	10.21	3.06	0.51	1.28	2.30	0.00	0.51	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	16.62	9.66	4.04	1.35	1.35	1.12	0.22	0.22	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	14.09	12.07	4.02	1.15	0.86	0.29	0.00	0.57	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	21.33	26.08	2.84	3.32	0.47	2.37	0.47	0.00	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	18.96	24.58	2.81	2.81	1.40	2.11	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	23.07	3.30	3.30	0.00	0.00	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	12.86	9.39	3.18	0.58	0.72	0.58	0.00	0.72	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	15.76	12.03	5.08	1.02	1.19	1.69	0.17	1.19	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	12.74	9.51	4.35	0.97	0.00	1.29	0.32	0.16	0.16	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	18.38	14.35	2.69	0.90	0.90	2.24	0.45	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	15.72	14.32	2.80	2.10	1.40	0.70	0.35	0.70	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	9.68	8.36	2.20	0.00	0.88	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	13.49	6.32	3.79	0.84	2.11	0.00	0.00	0.84	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	16.83	6.03	3.74	0.62	0.83	1.66	0.00	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	16.71	7.68	7.35	1.00	0.00	1.34	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	29.37	23.93	4.89	2.18	1.63	1.36	0.27	0.27	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	27.33	18.76	5.90	0.54	4.29	1.61	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	25.11	21.52	3.59	1.79	3.59	1.79	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	18.17	8.72	4.64	1.11	1.11	0.74	0.00	0.37	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	15.60	10.61	4.33	0.87	1.08	0.87	0.43	0.00	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	18.07	9.88	3.15	1.05	0.84	1.68	0.21	0.21	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	19.72	14.66	3.54	1.01	1.01	2.02	0.51	0.51	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	22.53	20.80	3.90	0.87	2.60	0.87	0.43	1.73	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	10.46	12.20	2.18	1.31	0.00	0.44	0.44	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	16.33	22.27	2.97	1.98	1.48	0.00	0.49	0.00	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	20.31	32.31	0.92	1.85	0.92	0.92	1.85	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	25.12	23.73	1.40	0.00	4.19	0.00	0.00	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	14.95	19.39	3.60	1.38	1.66	2.22	0.00	0.55	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	12.76	21.10	2.70	1.72	0.98	2.45	0.25	0.25	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	12.32	23.10	7.70	0.00	0.00	1.54	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	22.20	22.92	4.66	1.79	1.43	0.72	0.00	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	16.62	27.70	2.77	2.77	0.00	2.77	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	12.77	16.70	2.29	2.29	1.31	2.95	0.33	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	8.26	19.90	3.00	2.63	0.75	3.38	0.00	0.38	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	16.41	25.25	3.79	5.30	1.26	2.78	1.26	0.25	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	18.58	8.72	5.05	0.46	0.92	0.46	0.23	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	15.34	11.02	3.59	0.48	1.20	0.48	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	13.13	6.84	3.28	0.27	0.82	1.37	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	11.11	4.50	2.10	0.30	0.60	0.30	0.00	0.30	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	19.20	10.80	5.28	1.44	1.20	0.48	0.00	0.48	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	16.60	8.64	3.87	1.59	0.45	0.45	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	24.12	15.43	4.35	1.09	1.09	0.87	0.22	0.22	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	23.69	16.06	5.26	0.79	0.79	0.53	0.00	0.26	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	19.93	15.48	4.22	1.88	1.64	0.23	0.23	0.23	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	25.96	19.92	5.74	1.51	1.21	0.30	0.00	1.21	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	27.60	14.23	7.84	1.45	1.16	1.45	0.00	0.29	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	31.17	18.92	5.86	1.07	1.60	0.27	0.53	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	34.14	20.57	6.13	2.19	2.63	2.19	0.44	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	30.51	18.67	5.01	2.28	1.82	0.46	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	31.33	12.68	11.19	0.00	1.49	3.73	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	20.89	11.16	6.84	0.36	0.72	0.72	0.36	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	15.25	10.07	5.47	1.15	0.58	0.00	0.00	0.00	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	17.44	11.08	1.18	0.47	0.24	0.47	0.00	0.00	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	19.65	17.43	7.29	1.90	0.00	0.00	0.63	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	22.45	10.76	7.38	0.31	0.92	0.31	0.62	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	20.20	14.75	4.49	1.28	0.32	0.96	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	27.54	19.89	6.50	1.15	0.76	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	24.83	11.82	5.91	1.18	0.39	1.18	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	21.94	12.86	6.81	0.00	0.76	2.27	0.00	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	25.69	16.06	2.41	2.41	1.61	4.01	0.80	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	27.28	13.99	4.90	1.40	0.00	2.80	0.70	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	20.04	29.05	11.02	3.01	2.00	2.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	20.11	25.59	0.00	0.00	3.66	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	32.61	34.09	5.93	3.46	1.48	0.99	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	30.52	27.57	3.58	2.95	2.42	0.32	0.11	0.11	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	15.60	11.79	5.55	1.39	1.04	0.69	0.00	0.69	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	25.59	21.68	1.78	2.84	2.13	1.07	0.36	1.42	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	34.70	31.29	5.23	3.64	2.84	0.68	0.46	0.80	0.00	0.11
Chondrocyte - re diff, donor2	11339-117F7	9.85	6.27	0.90	0.90	0.00	0.90	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	24.26	21.43	3.64	0.81	4.04	1.21	0.00	0.00	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	40.05	54.51	2.52	6.31	4.36	0.80	1.38	0.57	0.00	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	33.99	55.58	4.49	5.99	4.28	0.86	1.50	1.92	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	39.65	51.33	4.51	6.99	5.22	1.50	1.68	0.71	0.00	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	36.59	35.21	4.59	6.51	3.67	3.39	2.66	0.46	0.09	5.87
Corneal Epithelial Cells, donor1	11526-119I5	28.76	16.47	6.15	1.32	2.85	0.00	0.00	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	18.20	11.38	5.69	3.41	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	25.82	17.38	5.88	0.77	1.53	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	9.74	3.63	3.14	0.17	0.33	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	8.83	2.84	3.15	0.32	0.32	0.63	0.32	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	8.10	3.89	1.62	0.22	0.43	0.22	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	17.42	21.52	1.02	3.42	2.05	2.05	1.71	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	10.45	17.63	1.31	1.31	1.96	2.61	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	7.26	17.42	1.94	1.45	0.48	1.45	1.45	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	25.52	27.02	3.50	4.50	1.67	0.67	0.33	0.17	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	22.88	29.34	5.28	5.87	1.76	0.00	0.59	1.17	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	34.22	29.13	3.96	5.09	1.41	0.28	0.28	0.85	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	23.20	31.85	3.15	1.97	2.75	0.00	0.39	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	29.96	32.29	1.75	6.11	1.16	1.16	0.00	0.87	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	43.29	45.41	4.71	6.59	3.29	0.47	0.47	1.41	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	31.73	34.54	3.51	4.56	2.45	0.18	0.18	0.88	0.35	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	24.38	25.71	1.99	2.88	1.11	0.22	0.22	0.66	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	22.82	18.86	1.52	3.35	1.52	0.00	0.61	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	14.10	15.79	1.97	1.97	1.41	0.28	0.00	0.28	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	23.77	31.50	5.35	3.57	1.49	0.00	0.30	1.78	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	19.79	23.43	3.64	2.60	1.04	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	39.98	39.56	4.40	4.96	0.71	0.14	0.28	1.28	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	27.61	20.01	3.60	2.00	2.40	1.20	0.00	0.80	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	34.07	48.22	4.72	1.57	2.10	1.05	0.00	2.62	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	25.35	22.61	2.48	1.62	3.60	0.50	0.12	0.12	0.00	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	16.73	20.64	4.35	1.09	2.39	0.22	0.65	0.22	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	21.25	24.43	2.08	3.54	4.64	0.49	0.12	0.00	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	30.71	42.09	10.24	7.96	2.28	0.00	0.00	3.41	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	39.81	51.69	4.89	6.99	4.89	0.70	0.00	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	36.74	43.33	5.18	5.50	4.24	0.31	0.79	0.47	0.16	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	21.45	18.15	6.60	0.00	0.00	6.60	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	24.97	17.83	10.70	0.00	0.00	3.57	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	22.72	16.13	5.38	0.73	1.22	0.24	0.24	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	18.72	12.48	4.16	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.96	16.42	3.69	1.23	3.28	2.46	0.41	0.82	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	10.29	12.92	2.19	2.30	0.88	0.77	0.33	2.41	0.55	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	27.19	23.51	3.03	5.20	2.06	2.17	0.33	1.63	0.11	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	22.80	19.77	4.00	3.76	2.43	0.97	0.12	0.73	0.12	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	19.52	18.01	2.73	3.68	1.64	3.28	0.41	0.27	0.14	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.14	23.20	3.27	3.48	1.48	1.27	0.42	0.74	0.21	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	23.98	21.87	5.53	2.63	3.69	3.95	0.26	0.26	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	24.25	20.60	2.99	2.99	0.33	1.00	0.00	0.33	0.00	0.66
Fibroblast - Cardiac, donor1	11268-116G8	33.11	32.21	8.17	6.80	3.63	1.36	0.00	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	46.23	31.83	6.06	2.27	3.79	2.27	0.00	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	39.59	36.43	4.73	6.78	2.68	1.10	1.26	1.42	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	23.34	18.79	2.42	3.03	4.55	1.82	0.30	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	22.84	22.21	2.66	2.54	1.65	0.38	0.13	0.51	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	18.49	20.77	2.43	2.27	3.94	0.30	0.15	0.76	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	26.66	44.08	3.35	4.42	5.23	1.74	0.80	1.21	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	39.69	50.91	4.75	6.90	6.47	1.73	0.43	0.86	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	48.34	60.06	8.79	8.79	10.25	0.00	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	40.59	26.75	4.61	4.15	5.77	0.69	0.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	37.99	41.21	2.54	6.61	1.53	0.85	0.51	0.68	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	19.25	22.54	3.76	5.17	0.70	0.70	0.00	0.70	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	19.81	21.23	1.89	0.47	0.94	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	29.01	23.21	5.80	3.14	1.09	0.36	0.12	1.57	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	19.78	24.19	4.75	3.39	2.15	0.11	0.23	0.45	0.00	0.11
Fibroblast - Dermal, donor5	11454-119A5	21.98	24.77	4.71	4.88	2.97	0.52	0.00	0.17	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	25.34	27.77	6.01	3.74	6.33	0.32	0.16	0.00	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	17.91	16.03	4.58	2.71	2.08	0.83	0.62	0.42	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	33.54	24.63	6.03	2.88	2.88	2.88	0.26	1.05	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	38.61	36.37	5.01	4.22	3.95	0.00	0.53	0.26	0.00	0.00
Fibroblast - Gingival, donor3	11394-118C8	25.24	22.82	5.70	2.22	1.35	0.68	0.39	0.19	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	39.48	23.89	3.12	2.08	5.19	1.04	0.00	2.08	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	28.90	36.12	5.29	3.52	1.94	1.41	0.35	1.06	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	25.10	23.70	5.46	3.59	4.05	0.16	0.47	0.16	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	17.17	15.15	3.52	2.03	3.38	0.68	0.27	0.68	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	52.58	47.64	12.35	5.29	3.53	2.12	0.71	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	24.86	17.84	5.85	2.78	3.95	0.73	0.44	0.00	0.15	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	17.18	12.82	4.77	0.95	2.05	1.09	0.00	0.41	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	21.28	18.98	3.84	1.86	1.76	0.55	0.11	0.66	0.00	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	37.86	33.31	6.31	3.67	3.67	2.93	0.59	1.91	0.29	0.29
Fibroblast - Lung, donor1	11270-116H1	51.66	38.06	14.95	5.44	9.52	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	31.34	29.84	8.95	2.98	4.48	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	68.38	63.10	9.07	12.66	5.70	0.21	0.42	0.84	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	14.99	26.66	3.33	3.33	1.67	0.00	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	15.38	19.58	9.79	2.80	1.40	0.00	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	20.99	24.07	2.80	1.40	2.52	0.56	0.56	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	25.58	21.11	4.06	1.22	2.44	0.41	0.00	0.00	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	27.96	27.96	15.98	3.99	0.00	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	5.96	0.00	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	32.78	27.54	5.24	3.88	5.43	0.19	0.39	0.19	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	35.80	31.70	5.01	3.94	5.31	0.61	0.76	0.15	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	12.24	9.79	2.45	1.22	0.61	0.31	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	27.48	25.57	6.11	3.05	1.14	0.38	0.00	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	25.92	30.24	5.40	4.32	2.70	0.54	0.27	0.27	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	33.28	25.40	7.07	3.71	2.32	1.28	0.81	1.04	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	31.61	25.42	4.09	3.32	1.44	0.44	0.66	0.44	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	30.28	21.13	4.88	3.66	3.86	0.41	0.20	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	36.08	31.41	10.02	4.68	4.68	0.00	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	38.75	37.56	3.95	2.77	1.98	0.00	0.40	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	23.81	23.62	4.17	1.79	4.56	2.78	0.00	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	23.09	19.89	3.73	2.49	2.31	2.13	0.00	0.18	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	21.68	17.34	4.93	1.38	3.55	1.77	0.20	0.20	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	25.57	21.96	5.11	2.41	3.91	2.11	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	16.52	17.06	2.81	2.16	2.37	1.08	0.00	0.43	0.11	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	28.85	27.84	7.59	3.04	3.54	5.82	0.51	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	23.96	18.87	4.43	1.80	3.28	2.46	0.49	0.16	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	18.05	14.04	2.61	2.81	2.21	2.41	0.40	0.00	0.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	12.96	15.67	3.11	1.61	1.61	1.21	0.00	0.50	0.00	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	32.64	35.36	9.67	3.93	6.04	2.72	0.91	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	23.94	21.79	4.23	2.15	3.40	1.99	0.17	0.17	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	17.27	23.25	1.88	2.91	1.88	0.68	0.00	0.51	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	24.63	25.95	5.58	1.64	2.63	1.31	0.99	0.66	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	15.02	20.56	2.88	3.20	2.24	1.49	0.43	0.21	0.00	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	31.88	23.78	5.23	2.70	4.39	0.17	0.34	0.34	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	14.74	16.00	2.20	2.20	1.41	1.73	0.16	0.63	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.94	12.20	8.72	4.36	0.87	3.49	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	23.92	16.47	4.33	2.43	0.87	0.17	0.00	0.35	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	15.35	19.52	2.86	1.04	0.52	0.78	0.52	0.00	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	20.44	13.29	3.07	0.51	1.02	0.77	0.51	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	88.04	88.04	4.59	9.95	19.90	1.53	3.83	3.83	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	65.08	96.99	7.66	10.21	21.69	0.64	0.00	5.10	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	47.64	47.35	2.28	3.71	10.84	1.43	0.57	0.57	0.29	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	123.54	137.05	8.27	16.27	12.96	1.38	3.86	13.24	2.48	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	91.10	99.32	7.31	17.81	5.71	2.97	4.57	8.68	4.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	85.20	78.06	4.95	9.51	15.06	1.19	3.17	3.96	0.99	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	130.05	133.49	7.67	23.00	14.54	1.06	7.67	12.95	4.23	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	107.63	107.63	9.13	20.22	8.15	2.61	7.50	5.87	5.22	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	40.24	38.47	4.86	4.86	13.27	3.54	1.33	2.65	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	65.01	78.29	6.22	6.08	8.62	0.71	1.41	1.41	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	60.22	76.72	3.08	8.25	7.27	0.74	1.48	2.22	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	49.70	56.14	3.49	6.72	6.45	0.54	2.15	1.88	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	68.64	74.83	3.84	5.33	7.93	0.50	1.24	2.73	0.62	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	65.06	70.60	5.68	5.54	8.58	0.69	1.38	0.97	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	38.63	42.29	3.25	3.25	5.08	0.81	0.41	0.81	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	60.01	81.00	5.70	8.67	7.99	0.23	1.14	2.28	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	57.92	63.28	3.61	7.60	6.35	1.00	1.49	0.87	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	44.81	43.28	7.21	3.93	3.93	1.09	0.22	1.53	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	78.89	106.37	5.32	13.00	10.64	2.07	2.66	4.43	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	76.46	99.98	3.34	11.44	10.49	0.48	0.95	2.86	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	60.32	79.09	6.03	6.48	8.49	1.12	2.01	1.56	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	74.20	91.94	4.64	11.49	11.69	1.01	1.61	3.43	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	79.39	106.54	4.92	14.42	7.29	1.70	2.37	1.87	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	64.64	68.81	4.61	7.98	8.25	0.89	1.60	1.77	0.27	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	92.82	113.00	5.72	11.55	10.51	1.04	2.81	1.98	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	63.53	94.61	5.81	10.42	10.59	1.20	2.39	2.39	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	74.69	99.70	3.98	9.74	8.19	1.11	2.66	2.55	0.11	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	68.55	72.71	3.91	8.57	9.07	1.41	2.16	1.16	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	54.72	58.60	5.10	7.96	8.17	1.02	1.02	2.25	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	79.84	115.94	5.36	14.85	11.76	0.62	3.71	4.95	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	73.56	114.49	5.53	12.57	11.07	0.92	3.11	2.08	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	66.04	84.55	5.34	11.34	6.50	1.67	1.17	2.17	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	72.74	98.75	3.31	11.90	7.27	0.88	1.32	4.41	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	79.21	96.55	4.30	13.04	8.86	0.49	1.23	2.46	0.49	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	58.84	92.39	6.81	11.51	5.35	1.30	3.24	2.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	57.09	76.33	3.21	9.30	10.58	0.96	1.92	4.81	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	68.98	82.06	5.59	9.19	5.78	1.42	2.27	3.13	0.09	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	61.37	68.81	5.22	4.43	5.85	0.79	0.79	2.06	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	54.43	71.76	5.17	7.60	8.21	1.22	0.91	3.04	1.82	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	67.01	82.06	4.81	10.04	7.94	1.05	2.61	2.51	0.31	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	57.52	55.99	4.17	6.37	3.73	1.32	0.66	1.76	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	56.39	67.61	7.01	11.50	6.45	1.12	1.68	1.40	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	57.96	62.03	4.26	7.41	5.46	0.93	1.57	1.57	0.28	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	46.53	53.48	4.55	8.02	3.74	1.34	0.53	2.14	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	43.45	47.28	5.05	5.05	4.44	0.31	1.22	0.77	0.15	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	67.49	63.21	4.40	8.16	5.18	0.91	1.04	1.30	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	57.20	47.98	4.07	5.15	6.51	1.63	0.27	1.90	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	55.67	69.68	3.87	8.11	5.53	1.11	0.74	2.21	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	64.70	76.54	2.63	10.53	7.90	1.54	0.88	1.97	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	60.50	60.50	1.98	5.95	3.97	1.98	0.99	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	51.18	68.59	5.14	7.26	6.33	2.11	1.06	1.58	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	53.67	62.54	6.25	9.28	6.66	2.22	1.61	2.02	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	34.82	53.88	2.29	6.86	4.57	3.05	1.02	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	38.82	49.17	4.78	4.78	12.54	1.79	1.00	1.79	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	65.79	67.18	3.70	5.70	8.78	2.00	2.16	1.39	0.31	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	74.88	76.72	6.55	5.73	13.30	1.84	2.45	0.61	0.41	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	57.27	60.40	3.44	7.82	16.59	0.63	2.50	1.25	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	52.56	55.66	3.96	7.91	14.41	0.85	3.67	1.70	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	31.82	41.97	3.69	3.69	12.45	1.84	1.38	2.77	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	108.89	42.07	4.95	9.90	4.95	0.00	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	46.80	57.25	2.71	6.96	10.44	1.93	2.32	1.93	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	46.53	77.01	8.02	3.21	20.86	1.60	3.21	4.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	86.94	69.55	5.22	5.22	20.87	0.00	3.48	3.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	56.31	59.56	4.56	7.49	11.39	1.63	2.93	2.93	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	45.30	56.83	2.88	8.65	9.88	0.82	1.65	2.88	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	76.64	89.97	10.00	6.66	19.99	3.33	3.33	3.33	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	53.13	62.64	3.64	7.83	11.47	0.84	2.52	5.03	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	45.43	70.60	3.92	7.52	10.46	2.29	1.63	4.25	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	67.11	103.18	1.68	10.90	11.74	0.84	4.19	6.71	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	64.57	85.56	5.09	8.27	14.95	0.64	2.23	3.82	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	50.61	70.65	4.42	6.79	14.61	1.70	1.36	3.06	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	85.61	73.09	4.18	16.71	18.79	0.00	0.00	6.26	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	60.71	95.07	5.73	8.59	14.32	1.15	1.72	6.30	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	60.68	89.39	3.85	8.29	15.39	0.59	0.89	3.55	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	77.93	93.18	5.08	15.25	1.69	3.39	5.08	8.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	78.70	96.10	5.80	19.05	11.60	1.66	0.83	3.31	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	64.67	97.34	3.91	14.27	10.82	2.07	2.99	5.06	0.92	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	79.03	115.91	10.54	5.27	5.27	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	48.05	79.19	3.84	13.45	11.53	0.77	1.92	2.69	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	52.16	71.71	2.61	10.43	15.32	0.65	1.63	4.56	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	80.93	90.29	4.68	12.04	16.05	2.68	2.01	4.68	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	54.71	95.16	3.08	13.87	13.48	1.54	3.08	8.09	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	64.36	109.21	2.74	11.64	9.24	1.71	3.08	4.79	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	91.94	124.24	2.48	12.42	22.36	2.48	2.48	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	50.49	83.05	1.89	5.66	13.68	0.94	2.36	3.30	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	60.95	118.28	1.21	7.85	15.09	2.41	3.02	0.60	1.21	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	92.58	122.59	3.56	13.23	17.29	1.53	4.07	4.58	3.05	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	54.24	88.54	3.19	9.57	10.77	1.20	2.39	5.58	1.20	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	52.79	90.28	1.97	3.45	12.33	0.49	2.96	6.41	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	69.65	80.27	3.54	14.17	8.26	3.54	1.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	54.84	94.52	2.92	7.58	16.92	0.00	2.33	5.25	0.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	58.37	89.97	3.07	13.61	12.73	1.76	2.19	6.14	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	39.84	82.23	1.70	5.93	5.93	3.39	0.85	2.54	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	58.50	92.52	4.78	10.74	10.74	0.60	1.19	1.79	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	45.61	100.45	1.46	16.50	11.65	0.97	4.85	7.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	36.52	36.52	11.41	7.99	4.57	3.42	1.14	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	44.49	51.56	7.48	7.07	11.23	2.49	0.42	2.49	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	39.36	44.98	13.49	7.87	6.75	0.00	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	17.44	26.96	4.76	4.12	2.54	1.59	0.32	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.87	22.56	5.43	2.92	2.09	1.25	0.00	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	28.89	16.25	6.15	1.97	1.74	0.58	0.00	0.00	0.12	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	29.20	13.17	6.75	1.01	0.84	0.51	0.00	0.34	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	31.17	16.38	5.92	0.68	2.28	0.46	0.23	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	30.61	21.53	7.65	2.19	1.97	0.77	0.11	0.11	0.00	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	27.94	20.63	9.24	0.86	1.72	1.29	0.21	0.43	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	29.71	14.64	6.46	1.72	1.51	0.86	0.22	0.43	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	33.87	18.68	7.72	2.37	1.74	0.62	0.25	0.75	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	29.34	17.33	4.80	1.72	2.74	0.17	0.34	0.00	0.00	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	27.87	16.66	7.05	0.96	3.84	0.00	0.00	0.64	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	29.10	35.26	5.60	2.24	2.80	1.12	0.00	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	38.52	43.28	5.19	1.73	6.92	0.87	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	18.51	2.64	2.64	0.00	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	38.45	39.15	4.59	6.35	3.88	0.35	0.35	0.71	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	45.04	44.32	2.91	5.09	4.36	0.73	0.00	1.45	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	22.03	25.88	5.77	3.15	2.45	0.17	0.52	0.35	0.00	0.00
Hepatocyte, donor1	11523-119I2	20.58	23.00	6.05	2.42	2.42	4.84	0.00	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	47.40	39.86	8.62	5.39	11.85	1.08	1.08	4.31	1.08	1.08
Hepatocyte, donor3	11684-122I1	21.47	15.34	7.98	3.07	2.45	2.45	0.61	1.23	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	26.76	39.81	5.87	5.22	5.22	3.26	1.96	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	34.61	26.57	5.24	3.67	3.85	1.57	0.35	0.52	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	23.87	22.36	3.43	4.67	2.20	0.27	0.14	0.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	66.86	101.88	22.29	6.37	6.37	3.18	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	106.80	53.40	33.38	0.00	6.68	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	54.17	54.17	0.00	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	76.14	98.29	15.23	6.92	9.69	11.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	67.57	65.07	17.52	5.01	0.00	2.50	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	118.68	11.87	0.00	0.00	11.87	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	97.39	107.64	12.81	5.13	5.13	12.81	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	86.84	54.85	13.71	18.28	13.71	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	92.59	97.46	19.49	3.25	8.12	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	85.03	91.70	10.00	0.00	10.00	5.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	36.31	58.09	10.89	10.89	3.63	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	103.23	115.14	23.82	7.94	3.97	6.62	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	53.21	63.19	14.41	9.98	5.54	7.76	2.22	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	104.77	94.29	31.43	0.00	10.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	72.43	69.28	10.08	5.04	1.89	3.15	0.63	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	60.32	75.78	9.28	7.73	9.28	1.55	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	43.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	108.53	96.91	17.44	7.75	3.88	7.75	0.65	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	96.60	104.65	12.88	8.05	3.22	11.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	47.79	0.00	0.00	0.00	35.84	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	105.93	106.75	13.85	7.33	8.15	8.15	0.81	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	99.91	94.04	16.37	9.24	5.88	6.30	0.00	1.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	43.12	14.37	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	101.26	85.99	13.66	6.43	2.41	7.23	0.00	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	72.94	72.02	15.70	4.62	5.54	4.62	1.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	90.48	0.00	0.00	0.00	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	75.53	69.39	9.91	8.50	3.78	4.72	0.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	58.05	78.91	15.42	7.26	2.72	4.53	0.00	1.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	102.23	94.70	11.84	6.46	7.53	7.53	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	86.39	125.78	10.16	12.70	11.43	11.43	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	16.43	0.00	0.00	0.00	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	106.49	102.67	15.94	8.29	7.65	1.28	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	105.71	98.42	27.34	5.47	20.05	3.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	94.83	31.61	0.00	15.80	31.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	106.40	106.40	12.85	8.57	5.00	9.28	1.43	1.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	126.10	102.87	23.23	6.64	13.27	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	62.55	20.85	20.85	41.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	74.39	68.52	12.66	3.70	2.16	4.01	0.93	0.93	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	75.51	73.75	15.80	5.27	3.51	7.02	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	84.86	47.15	18.86	3.14	0.00	3.14	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	102.22	78.58	9.74	10.43	8.34	4.87	2.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	106.23	104.02	13.28	2.21	4.43	2.21	2.21	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	77.81	64.84	9.73	6.48	9.73	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	100.27	88.07	17.44	4.36	3.49	2.62	0.00	0.87	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	98.99	85.49	15.75	4.50	2.25	4.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	73.18	80.15	20.91	13.94	3.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	110.94	86.41	25.60	6.40	6.40	4.27	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	83.13	87.28	12.47	6.93	5.54	1.39	1.39	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	76.94	85.49	11.40	5.70	5.70	8.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	98.49	98.49	17.49	2.76	5.52	7.36	0.00	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	78.66	63.53	9.08	6.05	6.05	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	74.50	43.46	12.42	0.00	0.00	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	62.38	50.75	16.92	4.23	3.17	4.23	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	19.09	19.99	3.10	2.37	0.98	0.82	0.24	0.65	0.00	0.08
Keratinocyte - epidermal, donor2	11349-117G8	21.08	15.23	4.10	0.59	1.17	0.00	0.00	0.59	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	23.66	16.19	4.16	0.95	1.14	0.28	0.19	0.19	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	31.33	21.45	4.54	2.61	1.93	0.68	0.11	0.23	0.00	0.00
Keratocytes, donor1	11527-119I6	25.79	19.60	5.16	2.06	1.03	0.34	1.38	0.34	0.00	0.34
Keratocytes, donor2	11607-120I5	22.26	23.44	3.52	4.69	2.34	0.00	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	24.70	16.80	5.14	2.57	2.57	0.59	0.40	0.59	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	8.79	4.40	0.00	0.00	0.00	0.00	0.00	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	36.68	40.99	4.31	7.55	4.31	0.00	0.00	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	43.13	58.70	4.15	6.23	4.38	0.46	1.15	0.46	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	21.29	27.75	2.62	3.73	2.32	0.91	0.50	0.30	0.00	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	21.94	19.33	3.68	1.54	1.78	0.59	0.00	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	27.07	25.12	2.51	1.95	1.12	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	21.09	22.04	2.52	2.99	2.20	0.47	0.00	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	19.36	21.51	1.08	2.15	2.15	0.00	0.54	1.61	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	17.02	18.28	3.47	2.21	1.26	0.32	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	24.69	25.98	3.34	1.51	0.86	0.32	0.32	0.54	0.22	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	22.98	18.47	2.87	0.41	1.64	0.82	0.41	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	29.83	26.55	3.79	1.77	2.28	0.51	0.00	0.76	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	19.56	22.38	2.82	1.83	0.99	0.56	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	15.82	15.82	1.98	1.19	0.79	0.00	0.00	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	22.10	21.91	3.30	1.36	1.55	1.16	0.00	0.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	25.00	24.81	3.70	1.67	1.11	0.56	0.19	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	21.25	21.60	4.88	1.74	0.35	1.05	0.00	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	31.72	25.04	3.34	2.39	2.86	0.24	0.24	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	26.65	26.78	4.53	2.47	1.51	0.14	0.14	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	21.87	17.86	2.77	2.77	1.23	0.31	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	27.43	29.62	2.18	2.81	1.56	0.00	0.31	0.62	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	24.34	24.70	3.66	3.11	2.20	0.73	0.37	0.73	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	20.73	22.71	3.62	1.97	1.32	0.33	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	21.97	24.60	2.34	1.76	0.59	0.29	0.00	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	28.38	33.61	2.74	2.74	2.99	1.00	0.00	0.50	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	23.28	18.91	3.88	0.97	0.97	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	19.93	26.39	2.96	1.08	0.54	0.27	0.00	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	21.95	25.28	3.03	1.51	1.36	1.21	0.00	0.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	24.37	22.29	1.04	1.04	0.52	0.52	0.00	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	25.13	19.05	3.14	1.88	1.88	0.42	0.00	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	26.01	25.86	4.96	3.61	1.80	0.00	0.00	0.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	25.45	22.01	2.06	0.69	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	23.89	22.95	2.63	1.69	2.26	0.19	0.00	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	26.30	27.46	1.80	2.01	1.91	0.32	0.00	0.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	19.87	16.48	3.39	0.97	0.00	1.45	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	19.52	18.85	2.65	2.98	1.65	0.66	0.33	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	24.65	24.78	2.97	1.98	1.73	0.25	0.37	0.99	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	21.47	29.25	5.18	1.48	2.96	1.11	0.00	1.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	23.97	22.98	2.47	1.98	0.99	0.00	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	26.12	24.61	4.67	1.92	1.37	0.55	0.27	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	19.30	18.01	3.22	1.93	1.29	0.00	0.00	0.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	18.26	20.69	0.91	2.43	1.22	0.30	0.00	1.52	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	27.57	24.77	3.92	2.94	2.24	0.84	0.00	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.04	19.56	2.13	2.49	0.71	0.71	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	18.91	18.42	4.85	1.94	2.42	1.45	0.00	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	28.17	24.90	2.65	2.33	2.33	0.16	0.16	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	24.71	21.49	3.58	2.15	1.07	0.72	0.00	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	23.19	22.87	3.59	0.65	2.29	0.98	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	29.43	33.19	4.71	1.18	1.65	0.47	0.24	0.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	19.68	17.82	2.23	2.48	1.11	0.74	0.25	0.00	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	30.48	24.59	3.07	3.59	1.28	1.02	0.26	0.26	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.60	19.99	3.58	2.69	2.39	0.60	0.00	0.60	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	52.12	24.93	2.27	0.00	2.27	6.80	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	49.10	32.22	9.21	5.37	6.90	1.53	0.00	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	40.08	33.40	14.10	4.45	2.97	1.48	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	46.12	50.78	10.58	4.65	4.23	1.27	0.42	2.54	0.85	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	55.56	50.64	10.55	7.03	4.22	2.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	39.23	41.09	8.41	4.67	0.00	1.87	1.87	2.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	32.98	41.22	9.27	5.15	3.61	0.52	0.00	4.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	39.25	41.63	7.14	2.38	7.14	2.38	1.19	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	62.20	47.95	11.54	5.88	3.39	2.04	1.13	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	37.23	32.57	7.85	2.62	3.20	1.45	0.29	1.16	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	34.66	29.71	7.65	3.15	4.95	2.25	0.45	1.35	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	60.97	42.14	11.52	6.77	5.69	1.63	0.54	1.22	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	45.19	41.08	11.81	6.68	1.54	1.54	1.03	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	43.40	36.34	6.70	5.29	1.76	1.41	0.00	1.06	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	27.32	31.98	6.66	6.00	3.33	1.33	0.00	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	43.81	34.64	9.68	3.57	6.62	2.55	0.51	1.53	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	39.22	30.42	9.87	3.20	2.93	0.53	0.53	1.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	38.73	37.41	7.75	4.53	4.16	1.13	0.57	1.13	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	46.02	46.63	12.27	3.07	2.45	1.84	0.00	2.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	59.53	49.74	11.42	3.26	4.08	2.45	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	37.90	28.53	5.00	3.12	2.50	0.83	0.21	0.83	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	40.64	33.91	8.41	4.20	2.24	3.36	0.28	1.68	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	57.70	50.49	9.27	8.24	6.18	2.06	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	45.87	37.45	10.16	6.10	6.10	3.19	0.58	0.58	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	37.37	31.99	9.86	4.19	3.29	0.90	0.30	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	41.49	30.43	7.75	6.09	2.21	1.11	0.00	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	44.54	43.48	12.37	8.48	5.66	2.12	1.06	1.41	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	42.04	42.41	10.33	4.43	4.43	2.21	0.74	1.84	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	42.60	31.08	5.76	3.45	4.61	0.00	0.00	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	55.26	50.66	8.83	5.37	3.84	0.77	0.38	0.77	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	37.93	41.33	8.49	2.83	1.13	3.96	0.00	2.83	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	49.23	33.64	13.95	3.28	1.64	1.64	0.82	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	56.03	49.71	8.59	5.87	4.97	2.26	0.45	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	33.03	43.81	11.49	4.31	5.03	3.59	0.72	1.44	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	54.52	53.78	8.96	6.72	2.99	1.49	0.75	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	45.33	47.19	9.66	5.95	3.34	1.86	0.37	1.86	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	42.64	36.61	10.34	6.03	3.45	3.45	0.00	1.29	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	53.09	31.68	10.28	5.14	4.28	1.71	0.86	1.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	59.97	48.64	12.99	5.66	5.33	2.33	0.67	1.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	48.26	58.52	15.08	8.45	5.43	1.21	1.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	56.88	54.04	12.80	7.11	1.42	1.42	0.00	2.84	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	52.93	50.18	7.91	5.16	5.84	0.34	0.00	1.03	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	43.48	45.09	10.73	3.76	3.76	0.00	0.54	0.00	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	52.52	47.81	13.47	7.41	6.06	1.35	1.35	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	51.12	44.08	12.22	8.15	4.44	3.33	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	37.21	37.21	5.81	5.81	6.98	2.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	52.89	50.77	9.52	4.23	4.23	2.12	1.06	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	57.22	46.82	12.00	5.60	7.20	0.40	0.80	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	39.25	38.52	12.36	5.09	5.09	2.91	0.00	1.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	71.29	51.36	6.13	10.73	3.83	3.07	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	51.79	46.37	14.31	4.44	7.89	1.48	0.49	1.97	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	48.93	47.05	6.59	7.53	4.70	0.00	0.00	2.82	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	62.35	49.78	10.06	4.02	7.54	0.00	0.50	1.01	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	43.71	41.01	10.81	4.51	4.06	2.70	0.45	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	25.82	30.98	10.33	1.72	6.88	1.72	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	50.32	45.87	12.47	5.34	5.34	2.67	0.89	2.23	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	42.62	43.79	10.17	7.04	5.08	3.52	1.56	1.96	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	46.18	36.95	10.56	3.96	1.98	2.64	0.66	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	48.78	45.67	14.53	4.67	3.63	0.00	0.00	0.52	0.00	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	38.07	48.13	6.13	3.06	4.81	3.50	0.00	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	31.87	34.66	10.62	3.35	1.68	1.68	0.00	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	42.40	39.75	11.92	7.07	4.42	2.21	0.44	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	41.66	44.74	10.41	3.86	5.40	1.93	0.00	1.93	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	38.99	33.93	4.56	4.05	3.54	1.52	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	47.58	47.58	8.65	4.33	3.84	1.92	0.00	1.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	46.51	46.91	11.13	5.57	4.37	2.78	0.40	1.59	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	43.75	39.50	9.72	3.65	4.86	2.43	0.00	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	34.59	37.35	8.30	2.77	5.53	0.00	0.00	2.08	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	47.50	41.42	9.88	4.56	6.84	1.90	0.38	1.14	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	44.93	34.08	7.75	3.10	4.13	4.13	0.00	2.58	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	41.72	31.44	11.49	7.86	1.21	3.02	0.60	1.21	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	49.44	45.32	6.34	6.34	5.39	1.27	0.63	1.27	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	39.98	41.58	5.86	4.80	2.67	1.60	0.00	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	32.76	39.08	13.79	4.60	4.60	2.87	1.15	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	47.82	41.14	13.37	6.17	2.57	3.60	0.51	2.57	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	35.37	33.95	17.68	4.24	4.95	1.41	0.71	2.12	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	37.45	49.37	10.78	3.97	5.11	2.84	0.57	1.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	44.93	44.10	11.65	7.90	3.74	2.91	0.83	1.25	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	32.89	33.67	10.18	7.05	3.92	2.35	0.00	4.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	49.27	52.61	11.27	8.77	4.18	3.34	0.84	2.09	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	61.33	53.43	14.87	6.04	4.65	3.25	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	44.16	40.81	16.73	3.35	5.35	2.68	0.67	2.01	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	51.33	48.12	11.76	4.81	4.81	1.60	0.00	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	52.53	58.59	8.89	4.04	3.23	2.83	0.40	1.62	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	38.55	37.63	11.93	2.75	4.59	4.59	0.92	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	37.34	67.57	8.00	4.45	7.11	1.78	0.89	0.89	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	63.26	54.14	13.11	4.56	3.99	2.28	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	51.38	51.38	13.80	3.07	8.44	6.90	0.00	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	29.00	47.06	10.94	9.30	2.74	1.64	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	53.01	49.44	10.69	4.45	5.79	0.89	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	62.91	41.59	9.88	7.02	6.76	3.12	0.26	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	41.78	53.05	10.61	3.98	1.99	3.98	0.66	1.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	72.75	41.57	24.94	8.31	6.24	4.16	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	12.54	3.87	3.42	0.68	0.68	0.68	0.00	0.23	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	4.40	2.20	1.84	0.55	0.18	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	11.93	6.42	3.01	0.52	0.26	0.26	0.00	0.26	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	14.34	10.09	0.53	2.12	0.53	1.06	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	10.46	10.30	2.54	2.22	0.79	0.95	0.16	0.16	0.00	0.16
Mallassez-derived cells, donor3	11930-125I4	12.51	11.54	1.95	0.97	0.97	0.69	0.00	0.42	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	13.95	10.36	3.59	1.20	0.60	0.50	0.00	0.10	0.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	17.08	9.27	2.32	0.29	0.58	1.16	0.00	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	27.69	24.44	6.98	1.25	2.49	0.00	0.00	1.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	0.68	2.71	0.00	0.00	0.00	0.68	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	15.36	13.73	3.14	1.62	0.87	0.65	0.11	0.32	0.00	0.00
Mast cell, donor2	11565-120D8	19.91	23.48	3.57	2.97	2.38	2.97	0.59	0.89	0.00	0.00
Mast cell, donor3	11566-120D9	32.64	24.99	7.88	1.58	1.80	4.95	1.13	0.68	0.23	0.23
Mast cell, donor4	11567-120E1	33.86	21.81	9.22	5.14	3.19	3.19	0.18	1.24	0.18	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	14.97	7.10	4.88	0.89	1.11	2.66	0.22	0.11	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	14.59	8.17	3.50	1.75	1.75	1.17	0.00	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	24.21	15.37	5.85	2.18	2.18	0.92	0.34	1.26	0.11	0.00
Mast cell, expanded, donor8	11941-126A6	24.77	16.57	6.19	4.02	3.01	1.17	0.50	1.67	0.33	0.17
Melanocyte - dark, donor1	11502-119F8	33.33	31.14	2.59	4.08	1.99	0.99	0.20	0.30	0.00	0.10
Melanocyte - dark, donor2	11582-120F7	28.38	34.95	3.46	6.23	5.54	0.35	1.04	0.35	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	21.59	16.52	2.90	1.88	0.80	0.22	0.29	0.14	0.00	0.00
Melanocyte - light, donor1	11274-116H5	36.20	25.39	7.05	2.35	2.35	2.12	0.71	1.18	0.24	0.00
Melanocyte - light, donor2	11351-117H1	45.04	29.35	8.19	4.78	2.05	0.00	2.05	2.05	1.36	0.00
Melanocyte - light, donor3	11423-118G1	39.03	29.49	6.07	3.47	3.47	0.87	0.87	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	39.36	30.09	3.85	4.06	3.02	0.42	0.10	0.62	0.10	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	28.51	21.25	2.96	2.69	1.34	0.54	0.27	0.81	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	29.46	29.20	5.36	2.68	2.95	0.54	0.80	0.54	0.00	0.00
Meningeal Cells, donor1	11493-119E8	24.94	35.85	5.09	3.85	5.58	0.87	0.62	0.12	0.12	0.12
Meningeal Cells, donor2	11573-120E7	22.45	40.49	4.40	5.28	5.72	0.44	0.00	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	29.59	35.86	3.26	5.13	4.73	0.41	1.14	0.24	0.00	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	38.21	33.65	2.28	5.42	2.85	0.29	0.29	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	17.91	22.64	2.11	3.02	1.71	1.01	0.40	0.00	0.10	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	44.68	44.68	14.46	6.57	3.94	1.31	0.00	3.94	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	23.55	22.24	5.23	1.31	5.23	2.62	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	22.25	23.68	4.31	1.44	2.87	0.00	0.72	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	22.87	19.27	3.18	2.54	2.75	1.48	0.21	0.64	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	19.10	25.63	4.02	3.52	2.51	1.01	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	32.08	24.17	5.49	3.08	5.93	0.66	0.22	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	18.26	23.38	5.84	2.19	3.65	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	29.46	24.55	5.12	2.46	5.32	0.20	0.41	0.20	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	19.25	34.90	3.88	3.46	3.46	1.11	0.28	0.28	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	37.92	38.66	4.09	4.09	3.35	0.37	1.12	0.74	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	30.79	32.50	3.16	3.16	3.42	0.39	0.13	0.39	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	34.72	40.06	3.86	2.67	2.08	2.67	0.89	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	21.02	23.36	2.34	4.67	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	25.62	32.02	8.97	4.48	8.33	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	20.91	17.72	3.90	1.77	2.13	0.00	0.35	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	34.09	33.46	1.25	3.75	3.44	0.63	0.31	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	26.12	23.22	5.81	2.18	3.63	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	26.25	28.37	2.12	5.30	0.80	1.06	0.53	0.27	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	17.02	25.02	3.00	3.00	2.50	0.00	1.50	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	30.71	29.63	4.26	6.14	1.73	1.08	0.72	0.51	0.07	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	16.20	1.35	1.35	0.00	2.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	8.87	7.14	2.46	0.99	0.74	0.25	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	9.13	4.42	0.59	0.00	0.59	0.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	3.46	0.00	3.46	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	8.06	4.65	1.55	0.62	0.93	0.00	0.00	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	7.68	4.56	3.32	0.21	0.83	0.62	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	2.32	0.00	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	11.01	6.26	1.75	0.50	0.75	0.00	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.98	6.52	3.26	0.00	1.86	0.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	8.94	4.67	2.85	0.41	1.63	0.41	0.00	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.50	3.56	2.38	0.00	0.79	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	8.55	0.00	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	6.19	5.31	1.77	0.88	1.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.98	3.04	1.90	0.00	0.76	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	2.63	1.32	0.00	3.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	9.13	6.15	2.33	0.42	1.49	0.21	0.21	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1.84	1.84	0.92	0.00	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	6.26	5.07	3.28	0.30	0.30	0.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	5.03	5.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	8.78	5.27	1.51	0.25	1.76	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.18	3.09	2.61	0.24	0.48	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.87	3.87	1.66	0.00	0.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.29	3.91	2.07	0.46	1.38	0.23	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	8.83	2.52	1.68	0.21	0.63	0.00	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.99	3.47	2.45	0.61	0.20	0.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	8.80	5.79	1.93	0.43	0.43	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	6.89	2.45	0.89	0.44	0.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	7.23	3.94	1.53	0.00	0.00	0.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.56	2.53	1.01	0.00	1.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	3.31	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	6.52	3.53	1.63	0.00	0.27	0.27	0.00	0.27	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	7.65	1.76	1.76	0.59	0.29	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	2.18	2.18	0.00	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.57	7.21	2.40	0.00	0.96	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.00	1.60	0.80	0.00	0.80	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	1.37	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	12.01	8.51	2.50	0.00	2.50	0.00	0.00	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	5.26	3.07	0.88	0.00	0.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	1.10	1.10	3.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	3.20	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5.95	5.45	1.24	0.50	0.00	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.09	2.09	0.70	0.00	0.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	2.21	0.00	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	9.91	4.44	1.03	1.37	0.34	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.06	1.31	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.68	2.49	0.71	0.36	0.71	0.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	5.89	4.49	1.40	0.28	0.28	0.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1.66	0.42	1.25	0.42	0.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.08	2.91	1.75	0.00	1.17	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.14	3.02	0.90	0.30	1.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	2.50	2.09	0.83	0.00	0.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	3.69	1.85	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	3.41	1.71	0.57	0.00	0.57	0.00	0.00	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	5.80	3.04	1.66	0.41	1.11	0.14	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	4.92	7.00	0.26	0.52	0.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	3.43	1.29	1.72	0.00	0.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.08	3.81	0.00	1.27	2.54	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	4.54	3.74	0.80	0.27	0.53	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	4.79	3.29	0.60	0.90	1.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	6.78	3.39	1.27	0.57	1.27	0.14	0.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	8.28	3.82	2.55	0.32	1.91	0.64	0.00	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	2.43	3.54	0.44	0.00	0.44	0.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	4.93	2.28	1.52	0.38	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	6.25	5.40	1.14	0.57	1.42	0.00	0.00	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	2.21	1.23	0.98	1.47	0.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	6.52	3.26	0.65	0.00	3.26	1.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.00	2.06	0.88	0.59	0.59	0.59	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	5.48	2.88	1.73	0.58	0.86	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	7.01	5.36	2.06	0.00	2.06	0.82	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	7.74	2.08	0.89	0.00	1.19	0.30	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	3.77	0.00	0.00	0.00	0.00	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	0.00	1.78	0.00	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	13.80	7.56	5.59	0.66	2.63	0.00	0.00	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	15.78	5.26	3.16	0.00	1.05	3.16	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	10.48	5.54	2.97	0.40	0.99	0.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	9.31	5.59	3.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	6.38	6.76	1.88	0.38	1.50	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	10.39	5.33	2.40	0.27	1.07	1.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	9.61	6.11	2.15	0.57	1.47	0.23	0.00	0.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	14.73	6.63	5.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	13.19	9.53	4.03	0.73	1.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	6.22	6.22	1.56	0.00	1.56	0.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	9.62	4.28	2.14	0.53	2.14	0.00	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	3.86	3.86	3.86	0.00	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	19.19	10.10	4.04	0.00	2.02	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	7.59	1.69	1.69	0.00	1.26	0.00	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	2.72	0.00	0.00	1.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	1.91	0.00	1.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	4.53	4.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	3.26	0.00	3.26	0.00	6.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	4.75	0.00	0.00	0.00	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	0.00	0.00	0.00	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	21.97	24.78	2.80	4.31	3.66	0.65	0.43	0.65	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	23.52	24.04	3.14	2.09	2.61	1.05	0.00	0.52	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	18.02	15.35	2.67	2.67	2.00	0.67	0.00	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.69	17.11	4.17	1.25	1.25	0.83	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	22.44	17.68	3.80	2.66	1.52	1.33	0.19	0.19	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	9.58	20.75	3.19	1.60	1.60	1.60	0.00	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	21.08	14.28	5.44	1.36	3.40	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	25.73	0.00	3.68	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.83	21.76	3.77	4.19	2.93	0.84	0.84	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	21.15	18.36	2.32	1.86	1.16	0.70	0.00	0.23	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	30.81	26.75	2.70	6.22	3.51	0.54	0.81	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	23.13	23.76	5.05	2.94	3.15	0.21	0.42	0.21	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	28.29	23.83	4.96	4.47	1.99	1.99	0.00	1.49	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	18.41	28.96	2.17	2.17	1.35	2.44	0.81	0.27	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	20.17	17.68	2.95	4.76	0.68	1.59	1.13	0.45	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	33.64	39.68	4.08	5.06	3.10	0.33	0.49	0.33	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	20.23	27.52	2.37	4.01	3.83	0.36	0.55	0.91	0.18	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	27.58	25.46	2.65	3.71	2.12	1.59	0.00	1.06	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	16.81	30.62	2.40	3.00	0.00	1.80	1.20	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	18.71	18.38	1.31	1.97	1.64	1.64	0.33	0.98	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.93	20.00	4.23	2.93	1.30	0.49	0.65	0.49	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	27.34	28.75	2.65	4.59	1.94	0.88	0.88	0.53	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	26.02	22.50	5.63	6.33	0.70	2.11	0.00	1.41	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	18.85	20.23	2.30	2.76	0.92	0.00	0.00	0.46	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	29.89	25.06	4.82	6.75	3.21	1.29	0.64	0.64	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	17.59	22.76	1.38	5.52	1.72	1.72	0.00	0.69	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	27.81	22.76	5.06	5.06	2.53	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	21.61	28.96	3.12	3.12	3.12	1.78	1.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	22.44	20.75	2.12	2.54	3.39	0.85	0.85	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	22.55	17.33	2.14	0.95	1.19	1.19	0.00	0.47	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	27.04	23.61	3.43	1.72	4.72	2.15	0.00	1.29	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	9.03	0.00	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	28.99	29.66	7.33	4.00	2.67	1.00	1.00	1.00	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	20.74	21.19	3.61	2.25	2.71	2.25	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	21.03	18.25	2.78	3.97	2.38	1.59	0.79	1.59	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	15.79	19.50	4.64	2.79	1.86	3.71	0.93	0.00	0.93	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	21.95	24.22	1.51	2.65	2.65	0.38	0.00	1.51	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	24.44	23.79	2.93	2.93	3.58	1.63	1.30	0.33	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	21.79	23.10	5.23	4.79	1.31	0.00	1.31	0.44	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	20.81	30.76	1.81	4.52	6.33	2.71	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	20.28	12.35	4.41	1.76	2.65	0.00	0.00	2.65	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	24.60	22.60	3.32	3.99	1.99	0.66	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	24.80	21.33	5.46	3.97	3.47	0.00	0.50	1.98	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	20.67	16.08	2.30	3.45	4.98	2.68	0.77	0.77	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	36.29	36.60	2.42	4.23	4.54	1.21	0.00	0.91	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	29.18	28.07	4.20	2.65	2.87	0.22	0.88	0.44	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	31.17	24.40	4.07	2.71	4.07	0.68	1.36	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	40.88	35.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	29.87	28.05	4.88	1.22	6.10	1.22	0.00	1.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	23.92	14.79	5.67	2.83	3.15	2.20	0.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	29.36	23.30	2.72	1.21	6.05	1.82	0.61	0.30	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	30.85	15.03	3.16	1.58	4.75	1.58	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	26.07	39.68	1.13	7.94	4.53	1.13	0.00	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	15.17	5.06	0.00	0.00	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	13.17	14.29	2.24	1.99	1.74	1.12	0.50	0.25	0.12	0.00
Myoblast, donor2	11322-117D8	22.25	28.77	5.18	5.18	3.07	1.15	0.38	0.19	0.00	0.00
Myoblast, donor3	11398-118D3	15.13	14.29	1.51	2.52	1.51	0.00	0.17	0.34	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	16.78	15.47	2.92	1.17	0.73	0.29	0.29	0.44	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	12.61	13.53	2.15	0.92	0.62	1.85	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	14.17	17.49	2.11	2.41	0.30	3.02	0.00	0.30	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	13.44	17.85	3.13	1.47	0.74	2.02	0.18	0.00	0.18	0.18
Neural stem cells, donor1	11275-116H6	51.54	58.43	2.18	9.80	5.81	1.81	4.36	0.73	0.00	0.00
Neural stem cells, donor2	11352-117H2	46.22	38.51	0.00	9.63	5.78	0.00	11.55	0.00	0.00	0.00
Neurons, donor1	11494-119E9	60.31	111.51	5.69	30.72	6.83	4.55	37.55	0.00	0.00	0.00
Neurons, donor2	11574-120E8	75.08	113.82	7.05	29.72	13.65	3.08	18.93	1.98	0.44	0.00
Neurons, donor3	11655-122E8	36.18	71.53	4.11	27.13	7.40	5.76	18.91	3.29	0.00	0.00
Neutrophils, donor1	11233-116C9	17.63	8.35	7.42	1.86	0.00	2.78	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	11.60	0.00	8.70	0.00	2.90	0.00	2.90	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	10.38	6.72	3.67	2.44	1.22	9.16	0.00	0.61	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	37.28	33.72	4.63	4.39	4.39	0.83	0.36	0.47	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	47.54	58.28	4.88	8.47	4.56	0.33	0.33	0.65	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	26.47	40.51	4.61	6.82	3.21	0.60	0.80	0.00	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	18.17	20.10	4.13	2.75	3.17	2.48	0.14	0.14	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	19.40	18.67	4.78	2.61	3.33	2.89	0.14	1.01	0.14	0.29
Olfactory epithelial cells, donor3	11935-125I9	22.13	17.03	4.09	2.16	2.27	2.50	0.34	0.11	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	31.07	30.39	4.09	2.43	3.02	1.27	0.10	0.19	0.00	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	31.90	30.09	7.82	4.81	5.42	0.00	0.60	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	28.93	31.90	4.04	5.10	2.34	1.49	0.43	1.28	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	43.44	44.58	5.72	6.86	2.29	1.14	2.29	5.72	4.57	0.00
Osteoblast - differentiated, donor3	11425-118G3	31.66	24.21	4.34	3.10	2.48	0.62	1.24	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	63.91	64.89	6.84	8.99	6.25	1.56	2.35	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	30.90	25.99	1.40	0.70	7.02	2.11	0.70	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	45.14	48.34	3.73	6.04	3.20	0.89	0.71	0.36	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	25.35	22.32	3.37	3.71	1.52	0.76	0.17	1.10	0.17	0.08
Pericytes, donor1	11491-119E6	36.72	59.19	4.67	6.56	7.90	0.89	0.78	1.45	0.00	0.11
Pericytes, donor2	11571-120E5	47.76	83.98	6.79	8.60	7.92	1.58	2.72	0.91	0.45	0.00
Pericytes, donor3	11652-122E5	34.99	42.52	5.70	5.29	1.63	0.61	0.61	0.61	0.00	0.00
Perineurial Cells, donor1	11499-119F5	30.29	32.66	4.52	4.52	3.62	0.34	0.34	0.57	0.00	0.00
Perineurial Cells, donor2	11579-120F4	30.73	28.71	3.40	3.96	3.86	0.55	0.46	0.18	0.09	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	14.98	14.66	2.55	0.64	0.32	0.96	0.00	0.00	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	12.49	11.75	5.39	0.24	0.98	0.73	0.24	0.49	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	13.46	8.93	3.62	1.29	0.91	0.78	0.26	0.13	0.00	0.13
Placental Epithelial Cells, donor1	11278-116H9	66.49	36.59	11.24	5.26	4.78	1.43	0.24	2.63	0.72	0.24
Placental Epithelial Cells, donor2	11355-117H5	77.62	72.08	16.63	8.87	6.65	3.33	1.11	4.44	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	90.51	72.64	10.41	7.46	6.87	3.53	0.20	1.96	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	13.29	12.66	3.16	1.90	1.27	1.58	0.63	0.95	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	12.76	13.69	2.25	1.50	0.94	1.88	0.00	0.94	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	15.92	14.75	3.00	1.70	1.57	1.70	0.13	0.00	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	19.59	20.26	4.95	1.35	2.03	1.13	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	14.17	12.68	2.24	2.66	1.81	2.34	0.00	0.53	0.00	0.00
Preadipocyte - omental, donor2	11329-117E6	10.48	17.02	3.06	0.87	1.75	2.62	0.00	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	22.20	23.06	4.44	2.15	4.30	2.15	0.29	0.14	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	14.76	21.65	3.94	3.94	3.94	0.98	1.97	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	35.63	30.10	8.29	5.53	2.76	1.23	0.92	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	26.21	24.08	5.84	2.48	2.66	0.71	0.18	0.18	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	33.21	29.29	7.32	2.55	3.41	1.02	0.68	1.70	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	20.96	14.90	3.45	1.30	1.49	0.56	0.28	0.37	0.09	0.00
Preadipocyte - visceral, donor2	11357-117H7	20.25	23.01	5.52	2.76	2.76	0.92	0.00	0.92	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	21.21	20.27	3.87	1.78	2.30	0.63	0.10	0.94	0.10	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	41.18	37.71	2.56	5.28	3.47	0.45	0.60	5.28	0.15	0.15
Prostate Epithelial Cells, donor2	11331-117E8	20.31	20.45	3.25	5.15	1.08	0.81	1.08	2.30	0.00	0.27
Prostate Epithelial Cells, donor3	11404-118D9	9.80	5.08	2.20	0.24	0.06	1.29	0.00	0.24	0.18	0.06
Prostate Stromal Cells, donor1	11254-116F3	17.77	17.31	1.59	2.85	1.59	0.23	0.23	0.23	0.00	0.11
Prostate Stromal Cells, donor2	11332-117E9	25.64	24.92	3.77	3.59	2.87	1.26	0.18	0.18	0.18	0.00
Prostate Stromal Cells, donor3	11405-118E1	27.01	27.42	4.69	4.38	2.40	1.36	0.21	1.36	0.21	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	41.24	29.93	5.11	4.38	2.55	0.73	0.36	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	31.47	24.33	3.12	2.29	3.40	0.42	0.00	0.07	0.07	0.07
Renal Epithelial Cells, donor1	11517-119H5	65.43	57.82	10.65	8.12	9.64	0.00	1.52	1.01	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	29.88	41.97	6.40	2.85	4.27	0.71	1.42	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	30.91	35.04	4.13	4.02	3.18	0.21	0.00	0.21	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	30.64	33.36	7.49	0.68	3.40	0.00	0.00	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	20.35	27.90	4.72	3.23	1.89	0.00	0.13	0.54	0.13	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	21.54	26.86	4.44	2.66	4.66	0.67	0.22	0.89	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	57.89	44.58	6.65	4.66	3.99	0.67	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	44.90	35.21	5.50	4.40	5.28	0.22	1.54	1.10	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	46.40	48.90	6.27	6.27	2.51	0.00	1.25	1.25	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	61.59	60.48	5.27	5.83	7.21	0.28	1.94	0.83	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	27.38	19.06	7.78	0.54	3.49	0.81	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	24.04	13.49	2.11	0.00	2.53	1.27	0.00	1.69	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	43.00	39.73	6.36	4.44	3.09	0.58	0.96	0.00	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	48.74	39.93	4.41	5.96	4.93	1.04	1.81	0.52	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	41.78	67.08	3.70	12.22	7.11	0.57	0.85	1.42	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	40.14	54.54	4.12	5.15	3.09	0.00	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	18.32	26.60	4.01	3.76	1.51	1.51	0.25	1.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	43.57	23.52	6.95	3.07	3.47	4.14	1.20	2.14	0.27	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	25.91	24.12	2.68	0.89	2.68	3.57	0.89	0.89	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	15.96	20.36	6.05	1.65	3.85	7.15	0.55	1.65	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	20.88	21.46	1.74	0.58	2.32	4.64	0.00	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	28.87	36.15	4.81	2.47	5.85	4.03	0.13	0.78	0.00	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	62.66	64.85	9.33	5.86	9.33	4.27	0.60	1.09	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	64.69	55.32	9.82	6.92	9.70	4.02	0.45	0.67	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	51.35	57.93	7.94	3.85	9.06	2.23	0.62	1.12	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	70.86	73.07	8.74	8.16	9.32	3.96	0.58	1.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	63.10	78.58	10.40	6.01	10.17	5.32	0.00	0.69	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	48.47	45.32	10.27	3.83	8.08	3.15	0.27	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	61.42	64.59	8.62	4.69	6.05	2.12	0.30	1.51	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	66.12	65.05	7.88	5.38	10.57	2.51	0.18	0.36	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	50.50	54.80	10.62	5.59	8.89	3.59	0.43	0.29	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	68.25	74.80	10.62	6.87	9.66	3.43	0.21	0.97	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	69.26	71.03	10.40	7.52	10.40	3.10	0.22	1.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	39.38	34.99	8.79	2.87	9.18	4.78	0.19	1.15	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	64.28	63.54	9.78	5.87	10.81	3.73	0.37	0.93	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	47.54	51.86	9.58	6.01	7.14	4.13	0.38	1.13	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	48.17	44.19	10.09	3.58	9.69	4.51	0.27	0.00	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	63.47	58.02	9.15	6.52	8.57	3.21	0.68	0.68	0.10	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	70.08	69.13	8.98	7.07	8.78	4.58	0.38	0.57	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	46.24	53.93	8.97	3.84	8.76	4.38	0.32	0.21	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	54.94	63.07	8.69	6.17	7.85	4.20	0.28	0.56	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	67.68	59.81	10.60	6.32	10.08	5.81	0.51	0.85	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	44.12	46.49	8.57	4.92	7.84	4.56	0.00	0.73	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	68.67	62.79	10.67	5.89	8.22	4.66	0.49	0.74	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	77.50	74.01	9.54	6.45	9.94	5.78	0.40	0.67	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	47.88	44.11	11.32	4.72	8.02	5.90	0.47	0.47	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	64.09	62.30	10.52	5.16	8.33	2.78	0.79	0.99	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	68.75	65.94	10.06	3.74	10.29	5.38	0.94	0.94	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	47.90	51.01	9.75	4.77	7.88	5.18	0.00	0.21	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	54.64	51.98	8.41	4.42	7.08	2.65	0.22	0.66	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	63.08	59.11	11.07	5.85	8.98	4.60	0.63	1.04	0.21	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	47.51	51.55	9.56	4.44	8.48	5.38	0.94	1.08	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	52.11	60.80	8.17	5.11	7.83	5.96	0.00	0.85	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	59.38	60.92	8.87	6.17	8.68	5.40	0.19	1.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	48.83	48.49	10.49	6.36	7.22	3.09	0.52	0.69	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	46.91	62.14	8.37	6.04	9.19	3.43	0.27	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	53.03	59.10	10.67	7.55	9.03	3.78	0.49	0.49	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	49.08	44.99	10.06	4.60	10.06	1.36	0.17	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	64.21	70.58	8.58	6.07	10.21	2.37	0.30	0.74	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	61.31	55.44	10.93	6.40	8.80	2.40	0.27	0.80	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	42.86	54.34	6.64	3.32	5.53	3.87	0.41	0.97	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	83.10	84.29	10.24	7.62	14.29	2.14	0.24	1.43	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	74.37	83.04	14.51	9.27	14.11	5.44	0.60	0.60	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	58.58	63.66	10.45	4.52	9.42	3.67	0.28	1.98	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	70.57	69.52	10.13	4.19	4.89	3.49	0.70	3.49	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	35.96	30.83	6.65	2.72	3.63	3.02	0.30	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	71.47	61.32	11.50	4.04	11.26	4.04	0.61	2.20	0.61	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	40.32	33.48	7.71	2.33	4.22	6.26	0.15	0.87	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	56.58	49.89	9.73	3.65	6.69	4.26	0.00	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	53.65	57.87	13.56	4.22	11.15	4.52	0.60	6.33	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	70.80	55.19	10.63	6.56	5.88	4.30	0.45	7.92	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	56.91	56.01	12.58	3.29	5.09	6.89	0.30	2.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	38.85	33.89	8.27	2.48	5.43	3.54	0.71	9.92	1.06	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	59.55	44.61	7.47	3.42	7.47	2.99	0.64	10.89	5.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	37.86	30.65	9.62	1.20	8.41	3.61	0.00	1.80	1.20	0.00
Schwann Cells, donor1	11498-119F4	37.80	59.62	7.71	7.15	7.15	0.56	0.38	0.75	0.00	0.19
Schwann Cells, donor2	11578-120F3	20.41	37.43	13.61	3.40	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	45.35	54.99	6.13	7.01	4.82	0.22	1.10	0.88	0.00	0.00
Sebocyte, donor1	11220-116B5	16.98	14.79	2.19	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	14.25	15.62	1.84	2.76	0.46	0.46	0.00	0.92	0.00	0.46
Sebocyte, donor3	11378-118B1	31.74	28.86	4.33	1.44	2.47	0.41	0.41	0.21	0.41	0.00
Sertoli Cells, donor1	11255-116F4	38.10	36.45	4.97	4.97	8.28	1.66	1.66	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	22.59	22.59	2.82	0.00	5.65	5.65	0.00	0.00	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	30.97	29.47	3.34	3.17	2.29	2.38	0.26	1.94	0.00	0.00
Skeletal Muscle Cells, donor2	11358-117H8	60.00	70.84	5.06	8.67	10.12	2.17	0.72	2.17	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	76.92	106.18	10.03	10.87	13.38	1.67	4.18	2.51	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	20.27	28.75	4.56	2.83	3.14	1.10	0.31	0.16	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	19.77	28.09	4.46	2.82	2.38	0.15	0.30	0.45	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	20.93	32.63	3.85	2.77	4.77	0.77	0.31	0.00	0.00	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	26.97	29.61	3.65	4.41	2.77	1.13	0.38	0.25	0.00	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	28.82	38.67	5.14	4.99	3.57	0.57	0.14	0.29	0.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	33.83	33.33	4.37	4.07	3.67	0.40	0.30	0.40	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	32.69	48.36	2.70	6.74	4.30	1.43	0.76	1.35	0.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	42.70	61.52	10.13	5.79	7.24	0.72	1.45	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	39.90	53.11	4.54	11.70	4.82	0.96	2.06	0.83	0.28	0.55
Skin - palm, donor1	10286-104F7	10.74	8.06	2.69	0.00	0.00	2.69	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	13.26	13.41	2.45	1.87	0.43	0.00	0.43	0.72	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	17.18	15.54	4.91	1.64	1.64	7.36	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	18.31	15.45	3.38	2.21	0.52	0.39	0.00	0.91	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	10.01	10.01	2.22	0.42	0.14	0.83	0.00	0.56	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	10.27	7.74	2.25	0.28	0.14	0.56	0.14	0.28	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	23.89	16.70	4.23	0.63	1.06	3.17	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	13.94	7.79	3.00	0.60	0.15	1.57	0.07	0.45	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	24.69	27.46	6.48	2.78	1.54	0.31	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	19.34	23.79	1.56	2.00	0.89	1.78	0.00	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	34.09	42.32	2.94	3.53	3.53	1.18	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	33.15	27.84	5.75	2.65	2.43	0.22	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	25.60	28.35	2.76	5.51	0.39	1.58	0.39	0.39	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.86	35.54	9.27	3.86	3.09	0.77	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	46.03	50.04	5.00	7.01	6.00	0.00	2.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	39.26	37.93	6.12	5.32	2.26	1.06	0.80	0.67	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	30.37	28.82	5.10	2.44	2.66	1.11	0.00	0.44	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	10.88	15.88	2.05	2.82	1.66	0.90	0.13	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	25.07	24.42	2.60	5.54	3.26	0.00	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	21.56	21.56	2.36	1.77	3.25	0.59	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	24.91	24.77	2.85	2.85	3.13	0.43	0.57	0.43	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	39.53	34.65	6.02	4.72	3.09	0.49	0.49	0.33	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	18.57	21.61	3.04	2.13	1.52	0.91	0.00	0.30	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	45.97	54.55	7.58	6.57	4.55	1.26	0.25	1.52	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	36.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	36.72	39.10	9.54	1.43	5.25	1.43	0.95	0.00	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	18.58	16.07	3.98	2.36	1.47	0.15	0.15	0.00	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	18.73	26.69	3.87	3.23	3.23	1.08	0.22	0.00	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	24.98	26.24	2.52	4.09	2.31	0.00	0.10	0.52	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	33.57	31.71	4.02	6.50	2.63	0.31	0.62	0.46	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	35.57	24.79	4.31	4.31	3.23	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	25.70	24.51	3.89	3.89	2.69	0.60	0.60	1.49	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	45.06	43.70	6.49	4.78	6.49	1.37	0.68	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	32.59	30.63	3.85	4.55	2.12	0.24	0.16	0.31	0.08	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	29.89	25.76	4.93	5.84	2.42	0.81	0.40	1.51	0.50	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	25.26	23.67	2.05	4.10	2.50	1.14	1.14	0.46	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	30.79	32.61	5.43	6.64	3.62	1.21	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	16.43	14.57	3.44	1.85	2.91	0.79	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	15.85	17.98	3.33	2.40	2.80	0.27	0.40	1.46	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	26.42	29.18	4.51	3.76	2.50	1.75	0.38	2.88	0.13	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	17.76	15.98	1.78	1.27	2.79	1.27	0.25	0.76	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	35.28	35.43	3.77	4.98	3.02	1.06	0.00	0.45	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	38.26	38.26	4.50	3.75	3.75	2.25	1.50	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	115.01	19.38	11.63	2.58	3.88	0.00	1.29	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	68.37	77.20	8.84	9.77	8.37	1.40	0.93	0.47	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	31.81	39.38	5.55	7.57	5.05	0.50	1.01	1.01	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	23.50	29.77	7.21	6.27	2.51	2.82	0.31	0.94	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	19.47	17.99	4.13	4.72	1.77	0.00	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	25.91	21.41	4.17	3.58	2.25	0.17	0.58	0.08	0.17	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	24.29	30.83	4.20	3.27	0.93	0.00	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	30.65	28.78	5.32	4.46	2.01	0.86	0.72	0.58	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	39.77	40.28	7.14	4.84	2.29	0.51	0.25	0.76	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	29.71	34.97	5.83	4.70	0.94	0.38	0.56	0.75	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	15.51	16.63	3.77	2.24	2.52	0.14	0.42	0.28	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	23.96	26.31	3.27	4.86	2.43	0.75	0.25	0.17	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	34.76	36.67	5.71	3.81	5.71	1.43	0.95	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	28.63	25.44	2.69	1.71	0.73	0.73	0.00	0.24	0.00	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	17.45	18.34	2.65	3.09	1.55	1.55	0.22	1.77	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	22.82	17.55	3.80	1.46	0.59	1.17	0.29	0.29	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	23.13	22.35	3.30	3.50	2.72	0.78	0.58	0.58	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	13.49	15.60	2.12	2.12	1.85	2.12	0.00	0.26	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	8.93	7.44	2.23	1.12	0.74	3.35	0.37	3.35	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	17.97	22.28	2.87	2.87	0.36	1.08	0.72	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	10.22	14.48	3.12	1.70	0.85	1.42	0.28	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	18.51	10.63	2.36	4.33	2.76	1.97	0.00	0.00	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	14.22	11.94	0.76	0.76	0.51	1.02	0.00	0.25	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	28.75	21.96	4.79	1.60	3.19	1.20	0.40	1.60	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	17.14	19.23	5.02	1.67	1.25	1.25	0.00	2.09	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	21.54	21.08	3.21	0.46	0.92	0.92	0.92	0.92	0.00	0.00
Synoviocyte, donor1	11291-117A4	21.55	20.87	4.21	1.51	2.52	1.01	0.67	0.50	0.17	0.00
Synoviocyte, donor2	11368-117I9	27.49	27.99	4.02	2.51	1.17	0.50	0.00	1.17	0.17	0.00
Synoviocyte, donor3	11440-118H9	21.89	18.99	5.59	1.56	2.68	1.34	0.00	0.45	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	49.31	43.24	11.08	8.22	6.79	1.07	2.14	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	31.71	21.80	3.96	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	56.50	56.96	7.41	5.09	7.87	1.85	0.93	0.93	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	12.47	10.75	3.37	0.57	1.22	0.22	0.00	0.07	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	37.11	27.45	5.41	2.32	1.93	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	22.33	24.62	5.15	2.29	2.86	0.57	0.57	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	42.07	22.64	8.49	2.34	3.57	2.83	0.37	2.21	0.12	0.12
Urethra, donor2	10319-105A4	35.97	23.38	1.80	0.00	1.80	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	23.11	19.13	7.17	1.86	1.59	0.00	0.27	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	18.43	20.83	2.80	2.40	0.40	0.00	0.00	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	30.26	21.09	5.96	1.83	4.58	0.23	0.00	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	24.96	22.29	5.35	2.90	1.78	0.22	0.22	0.22	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	22.24	16.02	9.79	1.78	0.89	2.67	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	28.59	15.73	7.15	1.43	0.00	2.86	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	23.27	14.37	8.21	2.05	2.74	2.74	0.00	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	18.94	13.77	7.92	1.03	1.72	4.48	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	26.73	18.59	9.30	0.58	0.58	0.58	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	21.87	13.54	12.49	2.08	0.00	3.12	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	16.52	10.10	12.85	1.84	0.92	2.75	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	28.30	14.61	8.22	1.83	2.74	2.74	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	34.17	36.64	3.82	5.80	4.32	0.62	0.74	0.37	0.25	0.37
Wilms' tumor cell line:HFWT	10597-108E3	21.12	16.72	4.40	1.76	3.52	2.64	0.00	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	32.96	36.31	8.38	3.07	11.17	0.56	0.28	1.12	0.00	0.00
achilles tendon, donor2	10292-104G4	10.33	8.27	2.07	0.00	2.07	2.07	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	26.26	34.42	2.55	3.82	1.78	0.25	0.51	0.51	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	31.58	21.82	4.88	3.71	3.71	0.93	0.23	0.46	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	41.19	41.55	2.49	5.82	2.61	1.19	4.04	0.12	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	18.50	21.22	1.09	2.18	4.35	0.27	0.54	0.27	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	29.23	26.14	3.09	3.37	3.65	0.28	0.56	0.28	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	25.59	17.34	5.29	2.54	0.21	0.42	0.00	0.63	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	41.10	45.46	6.26	6.53	4.08	2.45	1.09	1.36	0.54	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	28.20	33.49	4.85	4.41	5.73	0.44	0.88	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	28.99	23.68	2.45	1.23	5.72	0.41	0.41	0.41	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	25.24	25.63	3.88	5.05	0.78	0.00	1.16	0.78	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	23.55	20.98	4.05	1.84	0.74	0.37	0.18	0.37	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	23.40	7.80	0.00	3.90	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	18.36	15.34	1.39	2.56	2.79	0.46	0.23	0.23	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	34.69	31.33	8.80	6.21	3.88	1.81	0.78	0.26	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	28.64	21.04	7.31	3.51	5.26	0.58	0.29	0.88	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	27.89	17.20	4.65	0.93	2.32	0.00	0.46	0.46	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	34.96	28.79	11.93	2.06	4.11	0.41	0.41	0.82	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.64	14.73	8.90	2.15	1.84	0.00	0.61	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	29.44	17.07	4.27	2.56	0.85	0.00	0.43	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	19.71	17.29	4.25	2.43	3.94	0.61	0.30	0.30	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	28.64	14.20	7.22	4.33	2.65	0.48	0.24	0.48	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	18.26	9.58	4.45	0.67	1.11	0.45	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	23.35	23.35	5.00	2.67	2.67	1.00	0.67	0.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	31.59	26.01	1.86	1.86	5.57	0.00	1.86	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	33.90	48.59	4.52	4.52	6.40	1.88	2.26	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	30.97	30.09	5.67	1.31	8.72	0.87	0.87	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	22.49	11.25	1.87	3.75	5.62	1.87	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	20.02	9.42	7.54	1.18	1.88	2.35	0.00	0.24	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	19.39	13.03	4.81	2.79	1.55	0.93	0.31	0.47	0.62	0.00
adipose, donor1	10184-103D4	24.63	52.78	2.35	4.69	1.76	2.35	2.93	14.07	1.17	0.59
adipose, donor2	10185-103D5	85.16	95.70	8.11	10.14	3.24	2.43	4.06	4.87	3.65	0.41
adipose, donor3	10186-103D6	87.13	96.39	5.99	16.07	5.17	2.18	6.26	6.53	3.81	0.00
adipose, donor4	10187-103D7	54.61	39.00	1.73	6.93	6.93	1.73	1.73	0.87	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	23.20	15.15	5.21	1.74	7.42	0.47	0.32	0.00	0.00	0.16
adrenal gland, adult, pool1	10081-102A9	40.01	43.65	10.91	7.28	7.28	7.28	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	11.74	6.40	2.27	0.00	0.13	0.93	0.00	0.13	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	23.94	15.72	4.29	2.50	1.79	0.36	0.00	0.00	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	35.94	14.37	10.20	1.39	1.39	1.39	0.00	0.23	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	62.55	34.49	10.82	2.70	7.78	1.01	0.68	8.11	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	27.10	14.44	14.14	2.06	1.18	2.95	0.29	0.29	0.00	0.00
amygdala - adult, donor10196	10167-103B5	26.09	26.09	4.74	13.04	7.11	3.56	4.74	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	41.16	54.75	4.26	11.15	5.27	5.68	3.24	0.41	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	23.56	26.47	1.94	11.94	1.94	9.04	5.49	0.32	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	38.96	34.63	4.71	2.80	1.53	0.89	1.02	1.40	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	20.96	16.77	3.31	3.09	1.10	0.66	0.44	0.22	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	42.76	35.74	2.67	2.67	2.00	1.67	1.67	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	24.91	15.69	4.31	1.37	2.94	1.37	0.20	0.00	0.00	0.00
appendix, adult	10189-103D9	25.23	24.45	6.60	2.72	1.16	0.78	0.39	0.78	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	47.81	63.63	8.94	7.91	5.16	2.75	0.69	0.34	0.69	0.00
artery, adult	10190-103E1	46.20	58.42	6.79	5.43	6.79	1.36	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	22.31	19.56	2.03	2.03	3.62	0.72	0.43	0.29	0.00	0.00
b cell line:RPMI1788	10427-106D4	22.75	16.06	4.76	1.04	4.61	1.19	0.00	0.15	0.15	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	14.15	21.36	2.50	2.77	1.94	0.83	0.00	0.00	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	16.17	10.22	3.47	1.49	0.89	0.10	0.10	0.10	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	7.20	4.35	1.00	0.17	0.33	1.17	0.00	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	22.93	20.13	6.71	2.24	1.12	1.12	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	28.90	20.75	4.56	2.17	1.09	0.33	0.22	0.98	0.11	0.22
blood, adult, pool1	10053-101G8	22.15	13.29	2.21	2.21	0.00	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.13	8.56	3.43	0.86	1.71	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	26.32	23.62	5.40	1.35	2.02	1.35	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	32.80	49.20	5.13	16.40	11.28	8.20	5.13	3.08	0.00	0.00
brain, adult, pool1	10012-101C3	46.21	50.45	5.68	16.37	4.57	3.67	2.12	0.89	0.11	0.11
brain, fetal, pool1	10085-102B4	42.74	101.51	2.67	56.10	10.69	8.01	34.73	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	25.77	27.75	7.27	3.63	1.32	0.66	0.33	0.00	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	51.18	37.95	8.99	4.87	3.25	4.87	0.62	0.37	0.00	0.00
breast, adult, donor1	10080-102A8	41.67	17.68	4.42	1.89	7.58	0.00	0.63	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	13.08	4.45	4.32	1.02	0.76	0.25	0.00	0.13	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	17.01	17.93	4.64	3.40	3.09	0.62	0.62	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	23.48	12.43	5.76	0.46	3.68	0.46	0.00	0.46	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	37.04	20.09	5.81	0.97	1.21	0.73	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	33.85	29.15	2.35	2.82	11.75	2.82	0.94	0.94	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	30.95	25.60	6.13	4.59	4.48	0.98	0.22	0.33	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	35.81	50.70	3.49	5.70	2.22	0.95	1.58	0.95	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	55.36	72.13	3.73	9.05	2.66	2.66	3.19	0.53	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	35.69	27.63	2.30	10.36	5.76	6.91	4.61	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	52.54	59.40	3.51	15.90	7.36	5.86	4.18	1.00	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	42.03	55.02	6.11	12.99	5.35	11.46	5.35	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	30.76	46.51	4.03	17.95	6.59	15.02	10.25	0.73	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	32.05	43.70	5.83	8.74	5.83	11.65	2.91	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	71.10	91.17	10.89	23.49	16.65	21.78	4.06	0.64	0.43	0.21
cerebellum, adult, pool1	10083-102B2	28.29	47.95	3.79	14.49	4.14	5.86	3.10	1.03	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	50.65	58.12	5.81	12.45	3.32	24.08	2.49	1.66	0.00	0.00
cerebral meninges, adult	10188-103D8	37.82	51.44	6.05	8.82	3.53	1.26	3.28	0.76	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	19.73	12.43	3.65	5.85	2.92	0.73	1.46	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	30.77	18.12	6.18	1.29	0.00	3.45	0.14	0.58	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	20.05	12.43	2.49	1.66	0.33	0.17	0.33	0.33	0.00	0.00
cervix, adult, pool1	10013-101C4	35.07	32.86	5.35	4.83	3.46	0.42	1.57	0.52	0.10	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	23.13	25.22	1.81	5.16	3.76	0.98	0.28	0.28	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	7.84	6.53	2.61	0.00	2.61	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	42.01	26.10	8.20	2.49	1.24	2.73	0.12	2.24	0.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	33.39	18.36	3.45	1.72	6.28	1.72	0.12	0.25	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	21.82	9.49	6.88	1.42	0.71	2.61	0.24	0.71	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	32.48	14.53	7.41	0.85	1.14	1.14	0.00	1.71	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	43.95	35.40	5.07	6.46	5.57	0.70	1.19	3.38	0.60	0.10
chorionic membrane cells, donor3	12240-129G8	29.12	12.09	8.79	0.55	1.10	0.55	0.00	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	12.12	18.18	2.02	3.03	1.01	0.00	3.03	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	36.69	37.27	5.57	4.23	7.30	0.77	0.96	0.19	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	27.45	24.08	5.49	2.96	2.32	0.21	0.42	0.00	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	31.84	25.17	6.16	2.57	1.28	1.28	0.26	0.26	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	30.96	29.75	6.53	3.14	2.66	1.69	0.24	0.24	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	27.08	23.82	5.50	2.24	2.04	1.22	0.61	0.20	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	25.91	17.37	4.12	2.36	1.47	1.18	0.88	0.00	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	28.41	35.71	4.95	4.69	3.91	0.52	0.26	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	43.66	19.66	11.89	0.91	10.29	0.23	0.46	0.69	0.23	0.23
clear cell carcinoma cell line:TEN	10636-108I6	17.18	12.15	5.03	1.04	2.43	0.35	0.17	0.35	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	34.59	22.15	3.48	4.76	5.49	1.10	0.37	0.00	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	37.63	29.27	5.70	1.52	2.66	2.28	0.00	0.38	0.00	0.00
colon, adult, donor1	10082-102B1	35.70	27.37	4.76	2.38	1.19	1.19	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	37.01	21.74	9.28	3.64	2.47	2.35	0.12	0.47	0.35	0.00
colon, fetal, donor1	10070-101I7	43.88	31.52	9.27	2.47	3.09	0.62	0.62	0.62	2.47	0.00
common myeloid progenitor CMP, donor1	12130-128D6	22.92	64.17	4.58	4.58	13.75	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	50.07	0.00	0.00	50.07	0.00	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	12.75	8.92	2.12	0.00	1.27	1.27	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	24.90	11.47	4.23	1.06	1.96	0.91	0.15	0.00	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	18.90	11.56	2.96	1.41	2.40	0.85	0.00	0.00	0.00	0.14
corpus callosum, adult, pool1	10042-101F6	71.31	58.05	9.07	13.38	4.98	3.54	2.43	0.77	0.00	0.00
cruciate ligament, donor2	10295-104G7	16.21	12.16	0.81	0.81	2.43	0.00	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	37.72	30.50	2.41	3.21	6.42	3.21	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	30.24	38.88	5.76	14.16	3.36	2.64	2.88	0.96	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	17.91	29.62	5.74	3.44	2.07	0.46	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	19.75	10.00	5.13	2.05	0.26	0.00	0.26	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	12.52	8.43	1.20	3.13	1.20	0.72	0.24	0.24	0.00	0.24
ductus deferens, adult	10196-103E7	51.83	30.90	11.96	4.49	3.99	4.98	0.50	0.50	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	37.45	18.72	8.64	1.44	1.44	2.88	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	41.93	41.20	15.45	5.15	1.47	1.47	0.00	1.47	0.00	0.00
dura mater, adult, donor1	10041-101F5	16.19	17.43	2.15	1.73	0.50	1.49	0.17	0.00	0.00	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	36.64	38.42	4.66	7.55	4.00	8.44	1.33	4.00	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	34.39	44.85	4.87	7.74	5.73	2.15	1.58	0.86	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	19.73	4.93	2.47	0.62	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	23.31	16.04	4.84	1.21	2.42	0.30	0.00	0.30	0.00	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	17.91	10.19	3.09	1.23	1.23	0.62	0.00	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	14.45	14.45	3.94	0.00	1.31	0.00	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	26.82	22.46	2.68	2.68	8.72	0.67	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	32.98	10.51	7.61	1.09	1.81	1.63	0.00	0.18	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	35.38	27.18	4.82	2.89	4.34	0.96	0.00	0.96	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	19.45	17.45	3.22	1.00	2.33	0.44	0.22	0.11	0.11	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	33.33	20.90	3.74	1.98	1.87	0.22	0.11	0.00	0.00	0.00
epididymis, adult	10197-103E8	44.58	36.63	10.05	6.28	2.93	4.60	0.63	3.98	1.05	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	22.89	19.52	4.26	3.37	2.31	0.00	0.35	0.18	0.18	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.58	14.55	3.15	0.79	1.97	0.39	0.39	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	37.35	20.18	10.62	2.75	1.57	0.92	0.26	0.26	0.13	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	36.42	19.19	6.59	2.17	1.48	1.67	0.20	0.10	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	39.10	21.17	7.06	2.35	1.79	1.68	0.22	0.00	0.00	0.00
esophagus, adult, pool1	10015-101C6	26.44	14.33	5.42	1.91	1.70	0.96	0.53	0.42	0.21	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	25.17	21.67	3.13	2.76	4.01	2.13	0.00	0.38	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	16.90	21.73	0.00	2.41	0.00	7.24	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	21.04	16.83	4.21	2.10	2.10	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	23.81	14.88	4.46	0.00	2.98	1.49	0.00	0.00	2.98	0.00
eye - muscle superior, donor2	10297-104G9	19.49	14.90	4.59	1.15	4.59	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	8.74	20.40	2.91	4.37	4.37	1.46	4.37	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	46.02	44.49	9.15	12.97	2.80	0.00	2.29	1.02	0.25	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	12.69	8.08	3.08	1.03	1.80	0.26	0.00	0.00	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	25.17	13.53	5.22	2.37	4.51	0.24	0.71	0.00	0.24	0.24
frontal lobe, adult, pool1	10040-101F4	36.22	45.88	3.66	12.38	6.10	3.66	4.13	0.09	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	33.33	15.91	3.30	3.00	6.00	0.90	0.00	0.00	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	34.65	28.62	6.77	2.10	3.38	0.82	0.00	0.09	0.09	0.00
gall bladder, adult	10198-103E9	35.49	36.21	8.21	3.14	2.90	2.17	0.24	2.41	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	12.35	13.96	3.22	1.07	0.54	1.61	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	10.46	13.07	2.24	3.36	1.49	2.24	0.75	0.37	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	17.95	25.13	2.32	3.38	0.84	0.84	0.63	0.42	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	19.92	11.22	6.38	0.77	0.77	0.39	0.00	0.77	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	33.94	19.18	6.56	1.15	7.05	2.62	0.49	0.16	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	27.46	15.56	6.41	1.83	6.41	0.92	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	46.61	88.41	2.74	8.00	13.94	1.37	4.11	1.37	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	12.74	7.92	2.29	0.23	0.00	1.95	0.00	0.34	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	27.71	31.35	2.38	2.94	1.68	0.28	0.28	0.14	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	20.45	12.22	7.48	0.25	0.25	0.25	0.00	0.00	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	35.68	28.60	7.18	4.96	3.69	2.43	0.11	0.21	0.11	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	32.44	25.56	6.60	4.35	3.09	3.65	0.00	0.00	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	22.19	17.99	3.53	1.55	2.76	0.66	0.33	0.22	0.11	0.00
glioma cell line:GI-1	10413-106B8	26.65	23.72	3.81	2.64	3.81	2.05	0.29	0.29	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	30.61	27.70	4.37	5.10	2.92	2.92	0.73	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	67.13	44.18	9.52	11.47	6.10	5.86	1.22	0.98	0.00	0.24
globus pallidus, adult, donor10258	10367-105F7	20.54	27.38	6.85	5.48	4.11	2.74	2.74	2.74	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	28.24	31.44	2.66	11.72	1.60	6.93	3.73	2.66	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	26.92	73.41	12.24	2.45	2.45	2.45	4.89	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	32.79	21.86	0.00	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	15.68	5.23	0.00	5.23	0.00	0.00	5.23	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	16.32	19.84	1.60	1.60	2.24	0.96	0.00	0.32	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	37.19	40.86	2.75	6.89	10.10	2.75	1.84	1.84	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	37.95	31.55	6.40	5.03	14.18	0.91	1.37	0.46	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	28.34	34.14	2.58	3.86	10.31	2.58	1.29	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	20.12	11.50	5.75	2.87	10.06	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	29.49	26.75	3.43	4.12	6.86	1.37	1.37	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	33.10	30.90	6.62	13.24	6.62	12.14	5.52	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	21.84	16.38	3.74	1.15	1.44	0.29	0.00	0.00	0.00	0.29
heart - mitral valve, adult	10205-103F7	28.40	21.53	3.59	3.89	4.19	0.30	0.60	0.60	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	28.24	24.84	6.01	2.35	2.35	2.09	0.26	1.31	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	43.30	20.82	9.16	2.50	0.83	0.83	0.83	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	44.28	29.18	6.73	3.06	5.51	1.63	0.41	0.20	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	31.94	18.31	3.83	2.98	1.70	0.00	0.43	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	38.18	27.14	5.06	2.76	4.83	0.00	0.23	0.23	0.00	0.23
heart, fetal, pool1	10046-101G1	58.12	48.57	7.39	4.83	8.11	0.82	0.72	0.10	0.00	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	19.75	17.59	4.01	1.23	5.24	0.62	0.00	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	15.46	11.89	3.57	3.57	4.76	1.19	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	37.57	33.59	2.98	3.76	7.40	2.32	0.44	0.55	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	37.99	37.38	4.01	3.40	8.62	3.03	0.61	0.36	0.00	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	41.94	38.00	3.94	4.55	9.09	3.13	0.40	0.40	0.00	0.10
hepatoma cell line:Li-7	10484-107A7	26.69	25.69	2.45	4.34	2.67	0.33	0.33	0.44	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	18.99	18.49	2.01	1.91	3.02	0.30	0.20	0.20	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	22.71	20.82	6.62	7.57	5.68	2.84	4.73	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	51.64	59.80	4.90	12.25	6.12	5.10	1.84	0.41	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	22.41	24.90	7.47	9.46	3.49	4.48	3.98	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	28.20	55.34	3.52	20.44	5.64	10.57	12.34	0.70	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	25.02	32.35	1.22	2.44	10.38	1.83	1.83	6.71	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	59.69	55.37	4.71	5.69	14.14	0.39	1.57	3.73	0.20	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	50.78	52.30	5.59	7.62	13.96	0.76	0.51	2.79	0.25	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	99.24	94.17	2.82	20.86	14.10	0.56	5.07	19.74	2.26	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	121.10	135.56	6.71	23.24	10.33	1.03	8.00	25.30	4.39	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	111.98	140.84	5.69	23.54	13.67	1.52	4.56	34.54	4.18	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	77.37	81.16	6.71	13.72	4.96	0.88	5.84	16.93	7.01	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	90.05	97.80	8.40	21.97	7.54	2.15	5.39	18.96	5.60	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	102.60	93.01	5.42	17.52	6.67	1.67	5.00	16.27	3.75	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	79.09	98.74	5.21	20.60	6.63	1.18	5.92	13.97	0.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	94.98	107.36	8.68	24.59	7.55	2.09	6.11	15.27	4.98	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	74.06	99.65	7.41	22.22	6.73	0.00	10.77	9.43	2.02	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	55.71	48.20	3.60	6.73	11.89	0.94	1.41	3.44	0.47	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	44.71	44.71	6.39	5.90	11.30	1.47	1.97	4.42	1.47	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	15.71	23.56	0.87	1.75	3.49	1.75	0.00	2.62	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	129.06	158.46	9.93	23.10	14.13	1.53	5.54	18.90	1.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	110.33	135.18	9.16	25.73	10.90	2.18	7.85	16.57	2.62	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	66.47	100.45	1.50	7.50	6.50	1.00	5.50	12.99	6.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	59.15	74.60	5.27	9.80	5.46	1.13	4.52	11.12	2.26	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	52.29	62.75	8.64	12.28	5.00	3.64	3.18	10.46	1.82	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	57.32	62.65	5.64	10.96	3.13	2.19	2.82	11.28	2.51	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	73.65	102.39	4.74	18.13	3.10	2.12	5.55	12.41	1.96	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	70.84	86.22	5.23	16.84	3.77	2.90	4.06	14.23	2.90	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	76.23	90.57	3.29	14.35	4.18	3.59	5.08	6.28	2.69	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	68.17	64.85	4.99	5.73	16.81	1.85	2.22	6.84	0.18	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	60.20	47.36	7.13	6.56	17.12	0.57	1.14	3.14	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	35.11	41.65	3.67	7.35	11.43	1.22	0.41	5.31	0.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	72.53	94.36	4.22	13.38	10.56	0.70	2.82	18.31	2.46	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	85.52	100.72	6.97	17.10	12.04	1.90	2.22	16.79	2.22	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	95.02	118.32	4.24	13.62	17.55	0.61	6.05	15.13	2.72	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	73.43	68.26	4.14	13.45	3.62	3.62	2.59	5.17	2.59	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	67.08	65.75	9.30	8.63	7.31	1.99	2.66	11.95	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	62.08	70.29	4.10	11.54	3.85	2.57	3.59	4.10	1.80	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	57.52	81.04	4.35	16.87	4.86	4.86	4.60	9.46	1.02	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	77.99	76.48	5.30	13.63	6.06	1.51	7.57	15.90	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	58.81	66.20	2.69	15.12	4.37	2.35	3.02	7.06	1.68	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	64.00	58.93	6.04	7.00	18.35	0.48	2.17	6.52	0.72	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	54.37	50.81	5.35	8.91	16.04	2.23	1.34	4.90	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	51.22	48.78	4.39	6.83	20.00	0.49	2.44	2.44	1.46	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	102.08	125.61	9.47	24.76	14.06	2.14	4.58	25.06	3.36	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	29.28	29.28	0.00	13.01	0.00	0.00	3.25	55.31	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	53.61	68.17	4.30	13.57	5.30	1.99	1.99	32.43	2.32	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	90.85	92.49	8.21	7.11	6.02	1.09	6.02	13.14	2.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	69.48	72.38	11.58	8.69	5.43	2.53	5.43	14.84	2.90	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	62.28	69.39	3.56	14.23	4.27	2.85	5.69	17.44	2.85	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	63.25	85.92	2.39	15.51	4.77	1.19	3.58	15.51	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	75.03	97.10	4.06	20.31	5.28	2.98	6.50	19.09	1.22	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	63.85	91.59	4.31	20.47	5.93	2.16	4.85	8.62	1.89	0.00
immature langerhans cells, donor1	11904-125F5	8.96	7.75	1.94	1.21	0.97	1.21	0.24	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	18.22	19.01	8.71	3.96	1.58	1.58	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	43.25	55.83	4.54	18.55	5.58	4.64	4.07	0.19	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	25.69	17.88	4.23	0.98	0.00	0.65	0.00	0.65	0.00	0.00
kidney, adult, pool1	10017-101C8	34.44	25.73	5.11	3.90	1.80	1.10	0.40	0.50	0.00	0.20
kidney, fetal, pool1	10045-101F9	62.32	72.01	6.22	7.64	5.31	1.91	2.05	0.07	0.21	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	29.26	22.44	2.84	4.54	4.26	0.14	0.28	0.14	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	20.60	12.99	3.59	0.97	1.11	0.83	0.00	0.28	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	17.62	12.48	3.12	0.73	2.02	0.55	0.18	0.00	0.18	0.00
left atrium, adult, donor1	10079-102A7	27.24	14.71	4.90	2.18	5.45	0.54	0.00	0.54	1.09	0.00
left ventricle, adult, donor1	10078-102A6	24.27	20.73	3.54	2.02	4.55	0.00	0.00	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	17.24	17.51	1.92	3.28	4.38	0.55	0.82	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	15.81	21.91	2.51	2.87	0.36	0.36	0.36	2.16	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	8.15	13.59	4.35	3.26	1.09	0.54	0.54	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	15.78	16.27	4.86	3.64	0.97	0.49	0.49	0.49	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	19.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	18.82	17.77	7.32	3.14	1.05	1.05	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	31.64	40.97	4.72	4.25	3.19	1.18	0.83	0.24	0.00	0.12
liposarcoma cell line:KMLS-1	10782-110G8	27.81	18.59	5.62	4.37	2.66	1.56	0.47	0.31	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	20.10	25.34	2.07	2.19	3.53	0.85	0.49	0.00	0.12	0.00
liver, adult, pool1	10018-101C9	39.87	23.82	6.32	4.21	3.57	3.08	0.32	4.38	0.32	0.00
liver, fetal, pool1	10086-102B5	42.33	16.93	6.58	2.82	3.76	1.88	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	27.42	34.56	4.23	10.21	4.08	3.35	3.06	0.29	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	54.26	47.61	7.20	11.63	6.27	3.32	2.03	1.11	0.00	0.00
locus coeruleus, adult, donor10258	10375-105G6	37.24	47.40	5.92	19.47	6.21	4.23	6.49	0.85	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	19.35	21.45	0.84	7.57	1.26	5.47	1.68	1.68	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	16.75	5.40	5.40	0.69	2.08	1.38	0.00	0.14	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	21.37	11.72	4.83	0.69	4.14	4.83	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	13.71	9.89	2.64	0.40	3.16	0.79	0.00	0.00	0.00	0.13
lung, adult, pool1	10019-101D1	24.45	14.41	4.13	2.36	2.60	0.95	0.47	0.83	0.00	0.12
lung, fetal, donor1	10068-101I5	27.11	27.68	6.85	4.28	6.56	2.57	1.14	0.86	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	27.95	18.79	8.71	0.92	4.58	2.75	0.00	0.92	0.00	0.00
lymph node, adult, donor1	10077-102A5	14.67	11.83	2.37	1.42	1.42	0.95	0.00	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	17.32	19.29	5.70	3.29	2.63	0.88	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	12.68	9.21	1.21	1.06	0.30	0.00	0.00	0.15	0.15	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	6.80	7.65	0.85	0.00	0.85	0.00	0.00	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	24.42	10.21	4.44	0.89	0.44	1.78	0.00	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	20.75	13.49	3.94	1.87	1.45	1.45	0.00	0.62	0.21	0.00
mature adipocyte, donor3	12233-129G1	17.54	13.28	3.79	0.71	0.71	1.42	0.24	0.24	0.00	0.00
mature adipocyte, donor4	12234-129G2	23.16	16.32	4.21	0.53	2.11	1.32	0.00	0.26	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	37.41	16.44	7.39	1.43	0.71	3.81	0.00	0.48	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	23.69	28.20	4.51	6.77	3.38	3.38	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	50.57	56.28	6.25	15.82	6.25	4.23	2.94	0.55	0.18	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	24.78	35.26	5.40	13.03	4.45	4.45	4.13	0.32	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	6.40	25.16	2.99	3.84	3.41	4.26	5.12	0.43	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	36.96	43.03	3.54	13.33	5.23	5.23	4.05	0.84	0.00	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	43.51	52.63	5.52	12.73	6.79	7.85	2.12	0.21	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	26.97	11.56	15.41	5.78	0.00	9.63	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	22.97	42.35	1.44	14.72	3.95	10.77	13.64	0.72	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	27.91	21.42	4.54	3.89	3.89	3.24	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	52.01	43.35	7.59	8.51	6.50	5.57	2.79	0.15	0.31	0.00
medulla oblongata, adult, pool1	10038-101F2	38.28	38.69	3.75	9.63	3.35	3.27	2.04	0.08	0.00	0.00
medulla oblongata, newborn, donor10223	10361-105F1	47.56	46.87	4.17	12.15	4.17	2.43	2.08	1.04	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	67.31	89.89	4.65	8.41	5.98	3.32	0.89	0.44	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	22.38	17.24	3.18	2.32	4.28	0.24	0.24	0.24	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	7.33	3.45	1.72	0.00	0.43	0.14	0.14	0.14	0.14	0.00
melanoma cell line:G-361	10465-106H6	14.39	10.04	4.07	1.09	0.27	0.54	0.27	2.17	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	27.32	20.08	6.33	1.45	2.17	0.72	0.54	0.90	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	64.32	75.78	6.17	8.81	6.17	3.52	2.64	1.76	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	52.62	76.21	2.59	9.33	5.96	2.33	1.81	0.78	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	21.33	27.00	5.06	3.99	3.68	1.84	0.46	0.31	0.15	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	19.63	22.18	2.54	2.54	1.45	0.55	0.18	0.18	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.88	20.29	5.80	1.66	1.24	0.00	0.83	1.24	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	20.51	23.60	1.69	3.65	1.97	0.56	0.56	0.56	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	26.77	28.11	2.31	5.20	3.27	0.39	0.19	0.77	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	15.96	24.99	1.39	4.86	3.47	1.39	0.00	2.08	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	16.99	16.13	3.95	3.78	2.06	2.40	0.34	1.37	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	17.60	23.92	2.07	1.15	2.19	0.81	0.46	0.58	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	23.61	24.80	3.32	5.04	3.71	0.66	0.13	0.40	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	21.61	22.15	2.97	2.30	2.03	0.81	0.27	0.41	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	22.90	26.32	2.42	2.56	3.98	0.14	0.28	0.14	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	19.76	20.75	3.29	2.31	0.99	1.32	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	27.81	28.78	4.43	3.60	2.77	1.11	0.69	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	23.39	27.93	4.19	1.05	2.09	0.00	0.00	0.70	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	21.23	23.68	2.65	4.70	1.84	0.20	0.20	0.20	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	16.18	18.33	3.59	1.80	2.16	1.08	0.36	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	27.72	31.55	3.93	3.10	3.10	0.21	0.21	0.31	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.73	15.05	1.82	3.42	0.46	0.68	0.23	1.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	10.49	12.59	2.10	2.94	0.84	0.42	0.42	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	24.96	26.30	2.69	5.08	3.89	1.34	0.15	0.60	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	26.26	26.87	3.68	3.59	2.54	0.88	0.44	0.18	0.00	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	30.19	28.35	5.15	1.10	4.79	1.10	0.00	1.84	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	19.46	21.18	4.29	2.29	2.86	1.14	0.00	0.00	0.57	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	29.47	32.00	4.63	5.05	2.95	0.42	0.00	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	20.55	12.33	4.57	1.37	3.20	2.28	0.91	0.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	15.60	17.14	2.56	1.79	1.28	2.05	0.26	0.51	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	19.63	19.37	4.97	2.62	2.88	1.05	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	22.80	12.94	3.39	1.85	2.46	0.92	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	19.53	15.06	2.12	0.94	1.18	1.18	0.47	0.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	24.03	17.26	3.05	2.37	2.71	0.68	0.34	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	17.29	15.33	5.89	3.14	2.36	2.36	0.79	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	18.54	12.97	3.71	0.46	3.24	0.93	0.93	1.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	21.05	22.50	4.33	4.04	1.15	0.87	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	22.09	19.19	5.58	3.35	2.90	2.68	0.00	0.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	19.47	17.79	2.88	2.88	2.16	0.96	0.96	0.48	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	9.53	16.87	2.93	1.47	0.73	0.73	0.00	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	15.78	16.45	4.70	3.69	3.02	1.01	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	15.15	14.74	4.91	2.05	4.09	2.87	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	17.61	21.91	6.44	1.72	2.58	1.29	0.43	1.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	16.41	2.73	0.00	5.47	2.73	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	20.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	17.21	13.32	3.25	4.22	0.97	0.32	0.00	0.65	0.00	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	17.46	17.46	1.45	1.45	1.45	1.45	0.00	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	21.32	16.53	5.33	3.20	3.20	1.60	0.53	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	21.26	12.27	1.64	4.91	2.45	0.00	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	17.10	14.38	3.11	2.33	2.72	0.00	1.17	1.55	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	23.09	2.10	0.00	0.00	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	12.92	14.90	1.99	2.98	0.99	0.99	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	9.53	0.00	4.77	0.00	4.77	0.00	4.77	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	14.23	14.82	1.78	0.59	0.59	1.78	0.59	1.19	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	19.50	18.28	2.44	2.44	1.22	0.00	0.00	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	19.63	27.24	4.43	4.43	1.27	0.63	0.63	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	14.14	16.21	3.45	1.03	3.79	1.72	0.34	0.69	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	8.60	6.45	2.15	2.15	0.00	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	11.98	3.99	0.00	3.99	0.00	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	13.78	0.00	0.00	6.89	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	22.00	19.15	3.26	2.85	2.04	1.22	0.00	2.85	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	22.24	17.48	4.77	1.59	1.59	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	22.40	16.51	3.54	0.59	1.18	1.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.77	15.27	4.68	1.87	0.94	1.56	0.62	1.25	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	18.71	13.37	6.68	2.67	0.00	1.34	0.00	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	24.84	20.11	2.37	1.18	4.73	2.37	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	23.11	2.57	0.00	5.14	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	26.16	21.34	5.51	4.13	2.07	0.00	1.38	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	33.15	37.61	3.96	3.96	2.97	1.48	1.48	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	39.25	34.77	3.36	7.85	4.49	2.24	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	29.26	34.35	2.54	8.90	5.09	0.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	52.39	37.07	6.04	3.22	7.25	5.24	0.00	1.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	41.43	13.08	15.26	2.18	4.36	4.36	0.00	2.18	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	54.48	27.88	6.34	8.87	3.80	2.53	0.00	3.80	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	30.34	16.99	9.71	2.43	4.86	3.64	1.21	1.21	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	31.63	9.04	4.52	4.52	4.52	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	26.36	19.77	3.29	0.82	0.82	3.29	0.00	2.47	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	17.86	15.48	3.17	2.38	1.79	0.79	0.20	0.79	0.60	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	25.31	24.99	4.22	3.89	1.95	1.62	0.32	0.97	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	27.50	20.37	4.07	3.06	4.07	2.04	1.02	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	10.06	13.93	3.09	2.32	0.00	0.77	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	25.75	16.30	5.20	0.94	3.31	1.65	0.24	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	37.76	38.92	3.01	6.95	4.87	1.39	0.46	0.46	0.00	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	29.92	8.55	4.27	4.27	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	19.32	20.86	1.44	2.57	1.64	0.82	0.31	0.72	0.10	0.00
mesothelioma cell line:Mero-25	10850-111F4	5.90	8.85	1.13	1.82	0.23	0.23	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	31.78	28.36	7.82	1.96	2.20	0.98	0.00	0.49	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	23.03	15.94	6.64	1.77	2.66	0.66	0.22	0.00	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	21.02	26.02	4.73	3.42	1.31	0.53	0.79	0.00	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	33.53	32.85	5.28	3.23	2.72	0.85	0.85	1.36	0.17	0.17
mesothelioma cell line:Mero-84	10855-111F9	20.22	31.60	3.29	5.81	1.52	0.51	0.51	0.00	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	33.13	30.44	4.35	3.93	2.07	0.41	0.21	0.41	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	29.49	24.68	5.96	2.65	0.99	0.50	0.00	0.33	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	22.99	28.96	2.53	3.80	0.72	0.90	1.09	1.09	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	32.11	19.47	8.37	3.59	1.54	1.20	0.00	0.68	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	26.72	18.07	7.89	2.54	1.53	0.51	0.00	0.76	0.00	0.00
mesothelioma cell line:No36	10857-111G2	19.90	17.61	5.55	3.91	3.91	0.33	0.33	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	20.32	23.57	5.15	2.71	2.98	0.81	0.00	0.54	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	15.16	12.28	2.88	1.73	0.19	0.00	0.00	0.96	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	21.98	17.10	5.98	2.93	2.20	0.37	0.12	0.12	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	13.64	15.61	1.79	1.26	0.90	0.54	0.00	0.36	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	14.69	14.37	1.31	1.63	1.63	0.33	0.65	0.00	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	36.66	36.45	1.91	1.91	7.42	0.42	0.64	0.42	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	11.06	6.45	4.84	0.23	1.15	0.23	0.00	0.23	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	12.94	6.09	3.81	0.95	0.76	0.19	0.00	0.00	0.19	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	17.56	14.78	3.14	2.22	0.37	0.37	0.55	0.00	0.18	0.00
myeloma cell line:PCM6	10474-106I6	14.23	10.08	5.14	1.19	0.40	0.79	0.20	0.20	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	24.86	27.39	9.13	1.52	6.09	0.51	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	8.43	11.18	2.35	0.59	0.39	0.59	0.20	0.20	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	9.58	4.23	2.45	0.67	0.22	0.45	0.11	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	5.81	3.53	1.76	0.44	0.15	1.18	0.00	0.15	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	24.29	6.07	1.66	0.00	0.55	0.55	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	19.79	29.68	2.30	2.99	1.38	0.92	1.38	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	17.77	23.20	2.81	3.18	1.50	0.19	0.37	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	50.40	61.37	2.11	10.12	3.59	0.21	1.69	1.05	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	54.60	108.27	3.73	8.76	5.03	1.12	3.73	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	37.24	77.34	0.95	9.49	5.93	1.42	2.37	1.42	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	68.42	93.92	2.85	12.51	6.02	1.11	2.85	1.58	0.16	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	22.34	34.21	1.21	5.43	6.64	0.81	1.41	0.40	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	28.61	87.10	1.27	8.26	7.63	1.27	3.18	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	22.89	18.63	3.19	2.40	2.93	0.27	0.27	0.27	0.27	0.27
neutrophil PMN, donor1	12133-128D9	0.00	29.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	13.28	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	54.12	62.41	5.07	5.75	10.65	1.18	1.69	0.17	0.34	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	62.44	49.63	12.01	7.20	11.21	0.80	0.00	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	27.57	33.34	3.85	4.49	4.81	1.28	0.32	0.96	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	26.54	24.96	3.42	3.68	2.89	1.84	0.26	0.79	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	43.59	47.53	4.87	14.72	4.41	3.37	6.00	0.28	0.00	0.00
occipital cortex - adult, donor10196	10172-103C1	16.48	20.60	2.06	12.36	10.30	8.24	0.00	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	54.48	48.84	6.98	10.20	6.98	7.78	0.81	0.00	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	37.49	58.23	4.00	18.56	4.00	8.37	10.19	1.46	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	41.46	43.82	2.36	16.79	4.99	2.10	3.67	0.79	0.26	0.52
occipital lobe, fetal, donor1	10073-102A1	48.06	105.13	3.43	50.20	11.59	4.72	33.90	1.72	0.00	0.00
occipital pole, adult, pool1	10036-101E9	49.67	59.05	4.34	14.74	5.05	3.55	4.18	0.39	0.00	0.00
olfactory region, adult	10195-103E6	34.58	46.43	6.11	12.80	4.59	3.63	3.82	0.57	0.00	0.00
optic nerve, donor1	10277-104E7	62.03	56.03	10.01	20.01	6.00	6.00	4.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	21.98	11.28	3.87	1.25	1.25	1.48	0.00	0.34	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	30.36	30.91	2.89	1.65	2.89	0.55	0.14	0.27	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	18.63	19.30	3.56	1.02	0.85	0.00	0.34	0.85	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	13.98	12.71	4.04	1.73	1.50	0.00	0.00	0.23	0.00	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	25.87	21.75	5.59	2.35	2.65	2.35	0.00	0.88	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	18.69	10.28	1.87	2.80	0.93	0.93	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	22.05	33.93	3.18	5.09	6.36	0.00	0.64	0.42	0.00	0.00
ovary, adult, pool1	10020-101D2	39.83	39.48	3.32	9.96	2.36	0.79	1.92	0.87	0.17	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	12.47	13.02	2.57	0.92	3.12	0.55	0.37	0.18	0.18	0.18
pancreas, adult, donor1	10049-101G4	44.21	24.46	6.58	0.00	1.88	2.82	0.94	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	56.75	20.69	7.83	1.68	2.52	1.12	0.00	0.28	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	20.95	24.87	2.56	2.04	0.68	0.34	0.51	0.85	0.17	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	35.10	25.50	4.64	0.66	1.66	1.16	0.17	0.50	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	44.30	46.58	4.94	14.28	4.67	3.57	3.29	0.18	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	33.76	31.56	1.47	4.40	1.47	6.61	3.67	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	19.75	24.45	0.94	5.64	1.88	0.94	0.94	1.88	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	46.75	53.02	5.99	10.83	5.13	6.27	1.71	0.57	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	44.15	47.94	5.99	12.60	4.67	2.64	2.82	0.18	0.00	0.00
parietal lobe, fetal, donor1	10072-101I9	35.88	79.53	2.91	34.91	12.61	11.64	23.28	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	17.20	27.67	2.24	13.09	1.50	8.97	6.73	0.37	0.00	0.00
parotid gland, adult	10199-103F1	59.20	26.52	11.10	1.23	6.78	1.85	0.00	2.47	0.00	0.00
penis, adult	10200-103F2	40.82	31.69	7.52	5.37	2.15	0.54	0.00	1.07	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	21.94	27.89	1.86	2.97	1.30	0.93	0.56	0.74	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	19.81	15.59	3.06	2.04	2.19	0.58	0.44	0.15	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	16.13	20.64	1.94	3.87	2.58	6.45	0.65	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	21.32	29.02	3.55	3.55	2.96	6.51	0.59	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	26.96	31.35	3.14	8.78	3.14	5.64	1.88	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	66.78	46.54	7.08	3.04	15.18	10.12	0.00	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	75.05	54.20	9.90	12.51	9.38	12.51	1.04	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	41.71	63.84	8.51	12.77	10.21	13.62	0.00	4.26	0.85	0.00
placenta, adult, pool1	10021-101D3	30.64	18.49	6.88	2.37	1.29	3.87	0.32	0.32	0.00	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	20.13	18.67	3.05	1.46	1.85	0.66	0.00	0.53	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	18.83	15.56	2.33	1.71	2.65	0.31	0.47	0.31	0.47	0.00
pons, adult, pool1	10033-101E6	32.53	36.75	3.96	8.00	3.79	2.93	1.98	0.17	0.00	0.17
postcentral gyrus, adult, pool1	10032-101E5	49.43	59.80	6.28	18.39	6.28	2.70	3.31	0.17	0.09	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	25.10	37.65	4.18	0.00	4.18	2.09	2.09	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	22.03	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	22.29	11.65	4.37	0.58	2.77	0.44	0.15	0.58	0.00	0.15
prostate cancer cell line:PC-3	10439-106E7	38.66	24.68	5.63	3.45	8.89	2.00	0.00	0.18	0.18	0.00
prostate, adult, pool1	10022-101D4	44.08	31.83	7.71	5.53	4.35	0.45	0.73	1.09	0.18	0.00
putamen, adult, donor10196	10176-103C5	44.14	62.56	6.61	20.07	5.43	8.73	4.01	0.71	0.47	0.00
putamen, adult, donor10252	10152-102I8	43.14	21.57	3.92	5.88	13.73	5.88	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	15.30	18.58	2.19	7.65	7.65	4.37	4.37	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	37.21	45.66	6.28	13.53	3.14	3.62	4.59	0.48	0.24	0.00
putamen, newborn, donor10223	10365-105F5	10.50	8.25	1.50	3.75	0.00	7.50	2.25	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	15.71	10.47	2.91	0.87	2.33	0.00	0.00	0.00	0.29	0.00
rectum, fetal, donor1	10067-101I4	41.73	31.99	6.95	5.56	4.17	1.39	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	22.68	14.84	3.60	0.85	5.09	1.06	0.21	0.00	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	14.08	7.04	3.31	0.83	0.00	4.56	0.00	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	36.58	34.09	6.06	6.46	4.08	2.48	0.60	0.40	0.00	0.00
retinoblastoma cell line:Y79	10475-106I7	29.10	32.22	3.90	4.94	3.38	0.78	1.30	0.26	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	30.12	24.47	5.04	4.06	5.53	0.49	0.37	0.25	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	46.12	44.15	3.09	9.56	4.50	0.00	0.28	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	28.04	35.62	3.79	2.27	4.55	0.00	0.76	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	25.74	20.88	5.50	2.10	0.97	0.49	0.16	0.32	0.16	0.00
salivary acinar cells, donor2	11772-123I8	36.07	25.06	5.78	1.65	0.28	1.38	0.55	1.10	0.41	0.00
salivary acinar cells, donor3	11773-123I9	35.75	21.85	11.92	3.97	1.32	1.32	0.00	0.00	0.66	0.66
salivary gland, adult, pool1	10093-102C3	21.73	24.02	12.01	2.29	2.29	2.86	0.57	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	11.38	9.44	1.60	1.01	0.42	0.34	0.00	0.17	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	9.40	8.23	1.41	1.06	0.47	0.59	0.12	0.35	0.00	0.00
seminal vesicle, adult	10201-103F3	40.74	30.69	12.17	4.23	5.82	4.76	0.00	1.06	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	27.69	16.03	6.07	1.21	1.94	0.97	0.00	0.49	0.24	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	35.73	30.20	5.54	1.01	6.29	0.25	0.50	1.76	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	41.14	40.14	11.04	0.00	3.01	1.00	1.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	65.95	74.82	6.18	5.51	4.57	3.22	0.27	0.54	0.13	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	11.38	7.29	2.10	0.44	0.33	0.55	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	10.45	7.87	3.10	0.39	0.39	0.52	0.00	0.00	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	17.73	23.41	7.09	4.26	6.38	0.71	1.42	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	59.25	48.21	9.24	12.59	7.44	0.72	1.44	2.64	0.72	0.12
skeletal muscle, fetal, donor1	10066-101I3	47.24	72.36	3.02	12.06	5.03	1.01	1.01	2.01	0.00	1.01
skin, adult, donor1	10074-102A2	33.93	6.79	13.57	6.79	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	27.14	27.14	1.89	3.16	3.16	3.16	0.63	1.26	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	127.41	79.04	19.01	16.01	13.34	4.34	2.00	0.67	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	55.48	82.58	1.89	10.09	8.83	1.26	1.58	1.26	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	48.57	26.41	8.29	1.54	14.84	1.16	0.58	0.58	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	23.08	26.21	3.13	3.30	0.99	0.99	0.33	0.33	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	45.68	53.56	4.50	4.02	6.11	2.09	0.97	0.16	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	36.39	24.84	8.06	3.70	6.10	2.62	0.44	0.44	0.00	0.00
small intestine, adult, pool1	10024-101D6	26.99	15.65	8.72	2.27	1.07	3.11	0.36	0.60	0.12	0.12
small intestine, fetal, donor1	10064-101I1	28.75	20.39	5.65	1.47	3.44	0.98	0.49	0.25	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	38.98	32.31	9.75	3.59	3.08	1.54	0.00	0.51	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	22.74	14.73	2.58	2.07	2.07	0.78	0.26	0.52	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	21.17	11.79	5.90	1.88	0.80	1.07	0.00	0.54	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	25.23	33.72	4.82	9.41	3.21	5.96	1.38	0.92	0.46	0.00
spinal cord, adult, donor10252	10159-103A6	27.99	20.90	3.94	6.31	3.15	6.31	0.00	1.18	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	10.38	11.76	2.08	2.08	0.69	6.23	0.00	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	55.50	54.28	3.66	15.86	5.49	3.66	3.05	1.83	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	25.26	31.69	1.38	2.30	2.76	3.21	1.84	0.00	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	17.03	12.55	4.03	2.09	1.79	0.90	0.15	0.00	0.15	0.15
spleen, adult, pool1	10025-101D7	23.79	15.97	2.75	2.09	3.52	0.55	0.00	1.32	0.00	0.00
spleen, fetal, pool1	10044-101F8	34.88	26.54	4.37	3.81	3.02	1.11	0.48	0.48	0.00	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	14.60	10.56	3.62	1.14	1.24	0.41	0.21	0.10	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	13.10	7.78	1.33	0.19	1.14	1.14	0.00	0.19	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	58.71	46.48	10.13	3.84	12.58	2.45	0.70	0.00	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	10.56	8.60	1.95	1.56	1.17	0.00	0.39	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	19.14	14.52	4.16	1.91	0.34	0.79	0.34	0.00	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	24.15	15.25	5.93	2.12	4.66	0.85	0.00	1.27	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	24.96	17.77	9.73	2.12	2.96	1.27	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	16.02	21.36	3.20	2.14	1.07	2.14	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	30.76	22.22	10.25	2.28	5.70	4.56	0.57	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	64.18	50.47	7.69	9.14	3.53	8.10	0.62	0.62	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	25.35	25.86	3.62	9.83	3.10	4.14	2.07	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	31.80	28.26	3.53	5.65	4.95	6.36	2.83	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	55.94	42.41	6.42	5.73	9.63	0.92	0.46	0.23	0.00	0.46
temporal lobe, adult, pool1	10031-101E4	57.81	69.00	6.27	20.26	6.70	3.31	6.10	0.68	0.00	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	46.30	90.46	2.85	33.48	9.97	4.27	33.48	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	50.11	122.63	2.20	31.21	11.43	3.08	29.45	1.76	0.44	0.44
tenocyte, donor1	11763-123H8	40.50	38.40	5.24	2.79	4.54	1.40	0.00	1.05	0.00	0.35
tenocyte, donor2	11765-123I1	36.24	36.24	4.96	2.29	3.82	1.14	0.38	0.76	0.00	0.00
tenocyte, donor3	11768-123I4	35.58	34.47	9.27	3.34	3.34	2.97	0.74	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	23.28	22.60	3.23	2.72	3.06	0.17	0.34	0.17	0.00	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	39.77	49.48	2.31	4.16	8.02	0.62	1.23	0.92	0.46	0.00
teratocarcinoma cell line:PA-1	10807-111A6	34.41	29.76	2.48	3.41	4.03	0.31	0.46	0.15	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	32.75	30.21	2.67	3.17	1.40	1.02	0.63	0.89	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	20.04	14.75	6.43	2.27	2.27	0.76	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	7.85	6.00	1.31	0.33	0.22	0.00	0.00	0.22	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	36.15	23.45	3.91	2.61	0.33	1.30	0.00	0.98	0.00	0.00
testis, adult, pool1	10026-101D8	62.49	61.42	6.66	16.32	3.22	2.36	6.12	16.11	3.01	9.66
testis, adult, pool2	10096-102C6	44.66	68.11	8.57	13.98	2.71	10.83	6.77	1.80	0.00	18.49
thalamus - adult, donor10196	10168-103B6	41.95	15.46	5.52	9.94	2.21	3.31	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	55.48	47.51	5.63	10.94	5.94	6.72	0.94	1.25	0.00	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	24.63	9.24	6.16	6.16	0.00	6.16	3.08	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	26.19	36.40	6.09	10.05	3.29	4.28	1.81	0.82	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	12.08	17.26	0.58	8.05	0.58	11.51	2.30	0.00	0.00	0.00
throat, adult	10209-103G2	34.20	25.47	6.74	3.99	4.99	2.25	0.25	0.75	0.25	0.00
throat, fetal, donor1	10061-101H7	33.21	39.31	6.09	6.09	4.27	1.83	0.91	0.61	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	22.06	31.00	2.19	3.78	4.37	0.79	0.99	0.20	0.00	0.00
thymus, adult, pool1	10027-101D9	31.42	43.34	3.68	8.75	3.78	0.89	3.68	3.88	0.20	0.00
thymus, fetal, pool1	10043-101F7	34.60	38.03	2.29	7.90	3.01	2.39	4.36	0.94	0.10	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	22.87	21.67	3.46	2.13	2.66	0.40	0.40	0.40	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	19.42	18.58	4.19	3.77	1.82	0.70	0.28	0.56	0.00	0.14
thyroid, adult, pool1	10028-101E1	68.21	41.62	11.20	3.55	4.95	3.83	0.47	1.59	0.00	0.00
thyroid, fetal, donor1	10060-101H6	49.04	37.70	9.23	4.48	4.22	4.75	0.26	0.53	0.00	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	15.40	3.08	0.00	9.24	6.16	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	25.12	23.26	4.42	3.02	2.56	0.70	0.23	0.47	0.00	0.00
tongue, fetal, donor1	10059-101H5	33.89	28.77	7.09	4.73	3.55	0.00	0.79	0.39	0.00	0.00
tonsil, adult, pool1	10047-101G2	24.34	17.73	4.81	1.20	2.10	1.10	0.10	0.50	0.10	0.00
trachea, adult, pool1	10029-101E2	29.69	22.00	4.83	1.88	2.37	1.55	0.16	0.41	0.00	0.08
trachea, fetal, donor1	10058-101H4	35.39	31.16	9.23	3.46	5.00	1.15	1.15	0.38	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	17.36	18.07	1.77	4.61	1.77	1.06	0.00	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	26.54	26.24	3.24	2.33	3.55	0.30	0.30	0.10	0.00	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	25.85	17.39	5.80	1.41	6.11	0.47	0.00	1.88	0.00	0.00
tridermal teratoma cell line:HGRT	10694-109G1	19.03	19.03	1.90	3.81	3.81	0.00	0.00	0.00	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	27.51	22.60	6.01	2.03	1.95	0.68	0.25	0.25	0.00	0.08
umbilical cord, fetal, donor1	10057-101H3	31.30	12.52	0.00	6.26	6.26	2.09	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	29.35	28.49	5.80	3.41	2.05	2.56	0.85	0.34	0.34	0.00
uterus, fetal, donor1	10055-101H1	37.88	32.76	8.19	4.61	6.14	1.02	1.02	0.51	0.00	0.00
vagina, adult	10204-103F6	54.28	23.26	4.52	5.17	5.17	2.58	0.65	0.65	0.00	0.00
vein, adult	10191-103E2	23.89	22.14	3.95	3.73	2.85	0.44	0.44	0.88	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	7.48	10.41	4.01	0.53	0.00	0.00	0.00	0.00	0.00	0.00